Convulsions, not elsewhere classified

R18_CONVU_NOT_ELSEW_CLASSIFIED

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R56 Cause of death: ICD-10 — R56 2 out of 7 registries used, show all original rules.	14511
4. Check minimum number of events None	14511
5. Include endpoints None	14511
6. Filter based on genotype QC (FinnGen only)	12920

Control definitions (FinnGen only)

Control exclude: R18_GENERAL_SYMPTOMS_SIGNS

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R[5-6]
Name in latin: Convulsiones non alibi classificatae

NAME	R18_CONVU_NOT_ELSEW_CLASSIFIED
CONTROL_EXCLUDE	R18_GENERAL_SYMPTOMS_SIGNS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R56
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R56
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Convulsions, not elsewhere classified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	12920	5981	6939
Unadjusted period prevalence (%)	2.69	2.12	3.18
Median age at first event (years)	48.30	42.23	53.52

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
13344: Matched controls
131759

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

322.4

3511

18242

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

14.1

319.6

296

212

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

12.1

319.5

324

270

A06AD11

ATC

lactulose; oral

2.7

317.2

1921

7642

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.0

317.1

1597

5757

N05AX12

ATC

aripiprazole; systemic

4.1

314.4

903

2269

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

7.7

312.2

447

592

R11

ICD-10 Finland

Nausea and vomiting

3.2

311.5

1380

4619

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

7.5

307.8

452

616

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

8.5

307.7

2465

3429

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

43.4

307.7

1582

407

AA1BD

NOMESCO Finland

Extensive CT of head and brain

9.5

307.7

587

634

Z2445

NOMESCO Finland

Psychologist

4.5

307.7

939

2172

N03AX23

ATC

brivaracetam; systemic

56.0

307.7

223

N03AE01

ATC

clonazepam; systemic

5.7

307.7

1144

2147

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.6

307.7

1537

4583

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.3

307.7

1367

4360

G40.9

ICD-10 Finland

Epilepsy, unspecified

51.1

307.7

3176

801

AA1AD

NOMESCO Finland

CT of head and brain

7.5

307.7

6673

15514

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

54.0

307.7

2126

461

G40.89

ICD-10 Finland

Other epilepsy

46.8

307.7

342

N05BA09

ATC

clobazam; oral

39.2

307.7

457

119

N06AX16

ATC

venlafaxine; oral

3.0

307.7

2202

8255

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

9.0

307.7

538

614

S06.0

ICD-10 Finland

Concussion

3.5

307.7

2091

6621

Z3231

NOMESCO Finland

Registered nurse

2.2

307.7

3787

20241

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

4.0

307.7

1482

4013

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

58.5

307.7

2049

407

P16

ICPC

Acute alcohol abuse

7.4

307.7

503

691

N05CD07

ATC

temazepam; oral

3.3

307.7

1695

5624

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

9.0

307.7

423

476

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

4.3

307.7

1271

3151

N03AX16

ATC

[U] pregabalin

2.4

307.7

2724

12553

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

11.4

307.7

965

896

G40

ICD-10 Finland

Epilepsy

39.2

307.7

690

183

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

19.9

307.7

265

134

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

7.3

307.7

763

1082

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.5

307.7

1561

4814

N06AB04

ATC

citalopram; systemic

2.8

307.7

3038

12609

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.3

307.7

2530

8771

183

Kela drug reimbursment

Lamotrigin and topiramate

46.6

307.7

737

165

R53

ICD-10 Finland

Malaise and fatigue

3.2

307.7

3561

13357

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.8

307.7

2528

9993

F10.20

ICD-10 Finland

Alcohol dependence currently independent

11.3

307.7

748

686

XA400

NOMESCO Finland

EEG

27.6

307.7

327

120

N05AF03

ATC

chlorprothixene; systemic

6.4

307.7

596

960

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.6

307.7

4720

22733

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.4

307.7

6189

34817

R55

ICD-10 Finland

Syncope and collapse

29.0

307.7

2626

1102

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

5.6

307.7

661

1225

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.6

307.7

1237

3638

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

8.7

307.7

1102

1353

N03AB02

ATC

phenytoin; systemic

16.9

307.7

450

271

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

120.0

307.7

168

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.4

307.7

1590

3962

N03AX11

ATC

topiramate; oral

7.9

307.7

531

689

N05CD08

ATC

midazolam; nasal, systemic

9.6

307.7

676

726

W19

ICD-10 Finland

Unspecified fall

3.0

307.7

1698

6125

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

307.7

3049

14454

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.7

307.7

2035

6157

A28

ICPC

Limited function/disability NOS

2.9

307.7

2312

8946

N03AX18

ATC

lacosamide; systemic

61.0

307.7

708

121

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

46.7

307.7

435

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

10.8

307.7

560

532

N03AF01

ATC

carbamazepine; oral, rectal

9.5

307.7

1481

1703

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.3

307.7

2209

4712

N05AA02

ATC

levomepromazine; systemic

6.5

307.7

984

1603

F29

ICD-10 Finland

Unspecified nonorganic psychosis

5.0

307.7

932

1938

N07BB01

ATC

disulfiram; oral

6.7

307.7

1265

2030

N07

ICPC

Convulsion/seizure

75.4

307.7

262

TAB00

NOMESCO Finland

Lumbar puncture

5.0

307.7

805

1665

N88

ICPC

Epilepsy

59.9

307.7

558

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

5.1

307.7

3541

8687

WX892

NOMESCO Finland

Monitored bed care

4.0

307.7

1412

3756

X59

ICD-10 Finland

Exposure to unspecified factor

2.3

307.7

2950

14230

G40.10

ICD-10 Finland

Simple partial seizures

25.2

307.7

392

158

T36

ICD-10 Finland

Poisoning by systemic antibiotics

8.7

307.7

1433

1799

R40.2

ICD-10 Finland

Coma, unspecified

18.3

307.7

300

165

Z2446

NOMESCO Finland

Social worker

4.2

307.7

1351

3427

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.5

307.7

3678

17416

R56.0

ICD-10 Finland

Febrile convulsions

3760.4

307.7

741

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

13.9

307.7

430

316

R51.80

ICD-10 Finland

Headache

6.1

307.7

2293

4312

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

39.7

307.7

4597

1720

N06AX11

ATC

mirtazapine; oral

2.5

307.7

4944

25009

N05AH03

ATC

olanzapine; systemic

5.2

307.7

1585

3310

N05BA06

ATC

lorazepam; systemic, sublingual

4.4

307.7

851

1993

NA1AD

NOMESCO Finland

Cervical spine CT examination

4.5

307.7

884

2030

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

16.7

307.7

442

270

F10.09

ICD-10 Finland

Alcohol intoxication UNS

8.9

307.7

686

800

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

8.9

307.7

1111

1336

XA800

NOMESCO Finland

Neuropsychological investigation

5.9

307.7

1062

1901

N03AX14

ATC

levetiracetam; systemic

45.1

307.7

2597

702

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

67.0

307.7

822

129

N05BA04

ATC

oxazepam; oral

2.7

307.7

3925

17655

N03AF02

ATC

oxcarbazepine; oral

36.7

307.7

2540

838

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

30.2

307.7

611

209

N03AG01

ATC

valproic acid; systemic, rectal

15.8

307.7

2898

2268

N05CF01

ATC

zopiclone; oral

2.4

307.7

4235

21422

N05AH04

ATC

quetiapine; oral

3.7

307.7

3615

12065

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

3.4

307.7

1532

4776

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

64.9

307.7

220

G41.9

ICD-10 Finland

Status epilepticus, unspecified

37.5

307.7

391

106

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.7

307.7

3002

9666

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

17.2

307.7

301

177

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

14.1

307.7

458

332

N05AX08

ATC

risperidone; systemic

4.2

307.7

1706

4454

R50.9

ICD-10 Finland

Fever, unspecified

6.3

307.7

2174

3942

N05BA01

ATC

diazepam; systemic, rectal

5.9

307.7

3142

6491

P15

ICPC

Chronic alcohol abuse

7.5

307.7

1014

1426

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

10.4

307.7

681

680

N03AX09

ATC

lamotrigine; oral

8.0

307.7

1508

2075

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

14.6

307.7

340

235

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

33.6

307.7

413

125

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

54.1

307.7

300

R41.0

ICD-10 Finland

Disorientation, unspecified

7.4

307.7

675

944

XF400

NOMESCO Finland

ECG with 12 standard connections

3.7

307.7

2703

8459

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

65.1

307.7

777

125

F05.9

ICD-10 Finland

Delirium, unspecified

8.0

307.7

482

615

F10.24

ICD-10 Finland

Alcohol depence active use

13.5

307.7

596

456

R56.8

ICD-10 Finland

Other and unspecified convulsions

63812.9

307.7

12815

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

6.7

307.7

2226

3841

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

44.6

307.7

283

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

4.0

307.7

1720

4708

N05BA02

ATC

chlordiazepoxide; systemic

6.9

307.7

540

797

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

14.2

307.7

366

262

F10.25

ICD-10 Finland

Alcohol dependence continuous use

13.5

307.7

734

567

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

38.8

307.5

190

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

46.4

305.7

181

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.7

303.0

1937

7907

S01.0

ICD-10 Finland

Open wound of scalp

3.1

296.0

1343

4554

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.7

295.7

986

2752

N05AH02

ATC

clozapine; systemic

6.4

295.2

500

794

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

10.8

292.3

319

297

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

17.7

291.0

239

136

N03AX12

ATC

[U] gabapentin; oral

2.6

283.2

1906

7963

N05AD01

ATC

haloperidol; systemic

5.1

282.8

619

1250

ZXD05

NOMESCO Finland

Urgent procedure

2.0

279.0

3946

22455

N06AB06

ATC

sertraline; oral

2.6

277.9

1813

7456

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

24.5

274.8

196

R4110

NOMESCO Finland

Physiotherapy

2.1

273.0

3565

19677

P18

ICPC

Medication abuse

14.4

271.7

248

173

N02AA05

ATC

oxycodone; systemic

2.5

271.2

2069

9157

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.9

270.6

1452

5398

WX730

NOMESCO Finland

Conventional respirator

7.3

270.4

405

564

P19

ICPC

Drug abuse

8.7

268.0

344

399

N06AB10

ATC

escitalopram; oral

2.2

267.9

3001

15611

C03CA01

ATC

furosemide; systemic

2.1

264.8

3242

17440

L28

ICPC

Limited function/disability (L)

2.4

260.3

2213

10264

Z3226

NOMESCO Finland

Physiotherapist

2.3

259.8

2386

11438

Z72.1

ICD-10 Finland

Alcohol use

7.7

259.7

368

481

R42

ICD-10 Finland

Dizziness and giddiness

2.2

259.4

2741

13914

R60.0

ICD-10 Finland

Localized oedema

3.0

258.9

1295

4629

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

81.6

258.9

139

TKC20

NOMESCO Finland

Catheterisation of bladder

3.3

257.3

1023

3195

C07AA05

ATC

propranolol; systemic

2.2

254.4

2699

13711

G41.0

ICD-10 Finland

Grand mal status epilepticus

57.5

253.9

144

B18.2

ICD-10 Finland

Chronic viral hepatitis C

8.5

252.9

332

396

N03AX22

ATC

perampanel; oral

50.6

252.8

147

G72.8

ICD-10 Finland

Other specified myopathies

8.1

252.5

345

432

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

8.9

251.0

315

355

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.3

247.9

986

3079

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.7

245.4

807

2226

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.1

244.9

1089

3636

N06AB03

ATC

fluoxetine; oral

2.5

244.1

1671

7009

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

15.6

243.8

213

137

N05BE01

ATC

buspirone; oral

4.9

241.4

549

1144

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.5

241.1

1663

6998

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

30.5

240.4

159

N06AX21

ATC

duloxetine; oral

2.7

239.3

1459

5779

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.7

238.8

797

2220

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

4.1

238.6

696

1763

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.9

237.2

730

1922

SPAT1265

SPAT

Breathalyser

9.4

237.1

286

306

E87.6

ICD-10 Finland

Hypokalaemia

4.8

235.6

553

1183

Z72.2

ICD-10 Finland

Drug use

13.2

232.8

223

169

R52.2

ICD-10 Finland

Other chronic pain

5.8

231.6

431

750

R4120

NOMESCO Finland

Occupational therapy

3.2

230.9

1003

3300

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

230.8

4601

29018

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

12.7

227.2

223

176

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

7.1

225.2

346

495

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.4

221.6

1784

8038

N05BA12

ATC

alprazolam; oral

2.7

221.2

1295

5017

L01AX03

ATC

temozolomide; systemic

11.6

221.2

230

199

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.1

219.6

637

1606

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

18.3

218.5

176

ZY010

NOMESCO Finland

Hospital outpatient

3.2

218.2

923

2987

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

7.8

217.7

306

396

N02AX02

ATC

tramadol; systemic, rectal

1.8

215.9

4942

32358

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

7.0

215.7

333

479

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

6.6

214.0

348

529

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.8

213.3

671

1792

T90.5

ICD-10 Finland

Sequelae of intracranial injury

8.0

212.2

290

363

N04AA02

ATC

biperiden; systemic

6.0

211.9

381

641

K92.0

ICD-10 Finland

Haematemesis

5.2

210.9

447

876

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

210.6

4152

25936

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

15.1

209.7

186

123

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

7.2

209.5

317

446

WX882

NOMESCO Finland

High dependency care

4.4

208.4

536

1233

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

208.4

2614

14033

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

71.0

208.0

114

A02BC02

ATC

pantoprazole; systemic

1.8

207.6

7920

59805

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

17.3

206.3

171

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

18.5

205.9

165

F60.9

ICD-10 Finland

Personality disorder, unspecified

7.4

205.6

303

414

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

19.8

204.7

159

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

19.1

204.0

161

P29

ICPC

Psychological sympt/compl other

2.5

201.9

1368

5684

N05AB03

ATC

perphenazine; systemic, rectal

4.1

200.5

579

1454

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

5.1

199.9

431

857

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.8

199.6

638

1722

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.0

198.2

437

886

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

23.2

197.7

144

K70.1

ICD-10 Finland

Alcoholic hepatitis

12.8

197.7

193

151

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

8.1

197.6

269

335

XF600

NOMESCO Finland

Bloodpressure measurement

3.0

194.6

900

3064

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

26.4

194.5

135

SPAT1254

SPAT

Administration of medicine

2.1

193.5

2054

10332

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

5.2

193.5

407

792

N03AX15

ATC

zonisamide; oral

23.1

193.2

141

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

5.1

190.7

414

828

R62.0

ICD-10 Finland

Delayed milestone

38.8

189.4

117

N05CF02

ATC

zolpidem; oral

2.1

188.9

2078

10589

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.0

188.4

882

3022

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

187.8

3117

18331

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

6.1

187.6

333

553

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

22.8

186.8

137

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

7.0

185.3

285

408

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.6

184.1

623

1747

E86

ICD-10 Finland

Volume depletion

5.5

183.9

361

660

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

7.6

183.4

264

351

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.2

181.7

1839

9065

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

3.1

180.9

801

2657

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.0

180.6

844

2888

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

7.3

180.1

267

367

A41.9

ICD-10 Finland

Sepsis, unspecified

4.2

179.3

494

1197

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.0

178.7

864

3013

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.3

177.5

470

1105

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

7.7

176.2

250

327

G40.30

ICD-10 Finland

Benign myoclonic eplilepsy in infancy

25.2

175.8

124

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

14.6

174.1

157

107

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

11.2

171.9

183

164

JN3AD

NOMESCO Finland

Abdominal CT examination

2.2

171.3

1544

7253

R52.1

ICD-10 Finland

Chronic intractable pain

28.2

170.9

116

A03FA01

ATC

metoclopramide; systemic, rectal

2.0

170.3

2348

12935

D64.9

ICD-10 Finland

Anaemia, unspecified

2.4

169.3

1288

5625

ZXE20

NOMESCO Finland

More than three and less than five hours

2.2

169.2

1604

7689

N05AN01

ATC

lithium; oral

4.5

169.1

424

955

ZY000

NOMESCO Finland

Hospital inpatient

5.9

169.0

306

518

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

9.4

168.6

202

214

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

3.0

168.3

771

2606

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.8

168.3

918

3414

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.7

168.2

550

1506

N06AX03

ATC

mianserin; oral

3.4

168.0

631

1893

K90

ICPC

Stroke/cerebrovascular accident

4.5

167.8

426

969

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.5

165.6

1144

4780

N06AA09

ATC

amitriptyline; systemic

2.7

164.8

979

3802

R25.2

ICD-10 Finland

Cramp and spasm

4.5

164.8

417

946

A04

ICPC

Weakness/tiredness general

2.0

164.0

2071

11053

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.7

163.0

542

1501

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

162.3

1402

6463

Z2221

NOMESCO Finland

Medical doctor

1.8

162.2

3252

20133

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

13.1

162.2

156

119

C07AB07

ATC

bisoprolol; oral

1.7

161.8

5072

35482

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.4

159.8

607

1833

N05AB01

ATC

dixyrazine; systemic

7.0

159.2

245

351

P99

ICPC

Psychological disorders other

3.5

158.2

556

1597

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

5.3

158.0

327

627

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.5

157.1

553

1590

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.5

156.7

555

1602

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.0

155.7

724

2466

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

155.1

3241

20266

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

6.9

154.6

240

347

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.8

152.8

484

1296

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

152.3

1657

8360

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.4

151.2

301

557

V03AA01, ,

ATC

5.4

151.1

300

554

S06.3

ICD-10 Finland

Focal brain injury

6.1

150.3

265

437

PA6AD

NOMESCO Finland

CT of neck arteries

3.5

150.1

525

1503

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

150.0

2665

15863

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

149.9

1331

6198

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

18.4

149.3

120

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

16.5

148.9

126

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.9

148.9

764

2747

N06AA12

ATC

doxepin; systemic

3.2

148.8

620

1981

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

148.7

1067

4529

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.8

148.5

775

2812

F61.0

ICD-10 Finland

Mixed personality disorders

5.2

147.8

311

605

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.6

147.5

926

3691

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

12.6

147.2

145

115

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.6

147.0

511

1457

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

11.5

146.6

153

133

SPAT1227

SPAT

Substance abuse rehabilitation

9.1

146.0

180

198

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.9

145.9

442

1147

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

145.7

1201

5418

T74.1

ICD-10 Finland

Physical abuse

4.4

144.8

377

874

N02BF02

ATC

pregabalin; oral

2.7

144.4

808

3040

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.1

143.3

1539

7717

SPAT1240

SPAT

Therapeutic discussion

2.1

142.8

1515

7561

ZXE00

NOMESCO Finland

One hour or less

1.6

142.5

4460

30933

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

142.4

1099

4816

7803A

ICD-9 Finland

General symptoms, Convulsions

6.0

142.3

254

424

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

140.3

2182

12431

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

11.8

139.4

143

121

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

15.9

139.3

120

A01

ICPC

Pain general/multiple sites

2.3

139.0

1158

5244

N06AB05

ATC

paroxetine; oral

2.7

138.9

774

2904

A46

ICD-10 Finland

Erysipelas

2.0

138.7

1667

8703

G81.9

ICD-10 Finland

Hemiplegia, unspecified

8.3

138.7

184

222

EBA00

NOMESCO Finland

Extraction of tooth

1.6

138.2

4950

35412

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

6.4

137.9

232

365

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

137.9

1080

4762

SPAT1234

SPAT

Support of social functional capacity

3.0

137.5

622

2084

A10AB05

ATC

insulin aspart; parenteral

2.4

137.1

1020

4396

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

5.7

137.0

259

457

P74

ICPC

Anxiety disorder/anxiety state

2.7

136.8

791

3024

P72

ICPC

Schizophrenia

4.4

136.8

355

821

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

8.3

135.8

180

217

G41.2

ICD-10 Finland

Complex partial status epilepticus

36.7

135.5

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

10.8

135.1

147

136

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

21.1

135.0

102

G40.36

ICD-10 Finland

Juvenile myoclonic epilepsy [impulsive petit mal]

33.3

134.9

N06AA06

ATC

trimipramine; systemic

4.4

134.4

343

783

R52.9

ICD-10 Finland

Pain, unspecified

2.3

133.9

1100

4948

N02BE01

ATC

paracetamol; systemic, rectal

1.8

133.4

10986

95423

SPAT1247

SPAT

Outpatient detoxication and monitoring

10.5

133.3

148

141

A29

ICPC

General symptom/complaint other

2.0

132.6

1596

8330

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

132.1

786

3048

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.8

131.9

420

1128

SPAT1216

SPAT

Assessment of functional ability

2.0

130.7

1593

8347

X58

ICD-10 Finland

Exposure to other specified factors

1.9

130.6

2016

11437

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.6

130.5

801

3153

ZXD35

NOMESCO Finland

Usual procedure

3.5

129.8

461

1332

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

18.0

129.4

105

A86

ICD-10 Finland

Unspecified viral encephalitis

12.8

128.6

125

R33

ICD-10 Finland

Retention of urine

2.4

128.5

948

4067

M03BX01

ATC

baclofen; systemic

5.1

128.2

275

544

WX872

NOMESCO Finland

Intensive care

2.8

127.9

672

2444

P76

ICPC

Depressive disorder

2.3

127.7

1001

4410

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

12.1

127.3

128

105

SPAT1229

SPAT

Assessment of need for aid

2.6

126.2

770

3022

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

5.9

126.1

230

392

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

4.1

125.3

358

890

S00.0

ICD-10 Finland

Superficial injury of scalp

4.1

125.2

357

886

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

14.2

124.3

114

N05AA01

ATC

chlorpromazine; systemic, rectal

5.8

124.3

231

401

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.9

124.2

280

578

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

5.8

123.9

228

392

RS222, ,

NOMESCO Finland

6.2

123.2

211

338

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

122.4

1175

5627

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1536

5385

3.05

320.57

11.7

10.4

0.65

0.63

0.67

1527

5362

(3030467) Casts [#/volume] in Urine by Automated count

4552

26201

2.09

320.36

4.1

2.8

0.40

0.39

e6/l

0.05

3511

18379

(3006315) Basophils [#/volume] in Blood

7443

51056

1.99

318.60

8.2

5.7

0.04

e9/l

1.28

6388

43578

(3001604) Monocytes [#/volume] in Blood

7429

50939

1.99

318.23

8.2

5.7

0.61

0.58

e9/l

10.59

6378

43483

(3019309) Folate [Moles/volume] in Red Blood Cells

2860

13726

2.35

316.79

1.9

1.7

1176.04

1138.96

nmol/l

1.26

2247

10330

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

330

287

11.62

316.57

1.2

1.1

—

(3013115) Eosinophils [#/volume] in Blood

7618

52895

1.98

312.24

9.0

5.8

0.18

0.20

e9/l

9.85

6612

45913

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1321

4304

3.25

311.95

1.9

1.5

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1555

5574

2.99

311.64

11.6

10.1

1.44

1.29

6.01

1546

5547

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1993

8165

2.66

310.00

2.7

2.3

0.21

0.22

g/l

6.96

1804

7643

(3019198) Lymphocytes [#/volume] in Blood

7572

52561

1.98

309.46

8.3

5.7

1.93

1.98

e9/l

0.98

6632

46004

(3019069) Monocytes/Leukocytes in Blood

6949

46845

1.97

309.41

8.5

5.9

8.97

8.78

6.12

6574

43797

(3006504) Eosinophils/Leukocytes in Blood

6933

46713

1.97

309.02

8.4

5.8

2.63

2.91

20.99

6558

43656

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3189

14737

2.49

307.65

2.9

1.7

1.75

1.39

81.23

2825

13177

(3014111) Lactate [Moles/volume] in Serum or Plasma

2365

7442

3.60

307.65

9.0

8.0

1.49

1.34

mmol/l

6.46

2320

7283

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2190

8066

3.01

307.65

10.2

8.8

121.81

123.10

g/l

1.98

2157

7864

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2575

9015

3.26

307.65

2.2

1.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3347

12569

3.17

307.65

2.2

1.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2930

11322

2.99

307.65

7.0

5.5

1.05

mmol/l

0.46

2783

10506

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

7335

25200

5.16

307.65

3.6

1.9

278.07

236.02

u/l

1.54

7144

23699

(3002582) Erythrocytes [#/volume] in Urine

5108

30454

2.06

307.65

4.3

2.9

74.83

85.22

e6/l

0.21

4036

22422

(3003396) Base excess in Arterial blood by calculation

2689

9565

3.22

307.65

9.2

7.9

0.84

0.67

mmol/l

1.13

2216

7816

(3003181) Sodium [Moles/volume] in Urine

725

1162

6.46

307.65

1.6

1.5

65.21

65.76

mmol/l

0.09

567

919

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3843

13572

3.52

307.65

4.5

3.1

0.80

0.82

mmol/l

35.49

3672

12760

(3012544) pH of Venous blood

2594

8582

3.46

307.65

5.3

3.4

7.37

0.04

1614

4877

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1554

5029

3.32

307.65

10.8

10.3

24.17

24.09

mmol/l

0.34

1524

4913

(3024561) Albumin [Mass/volume] in Serum or Plasma

6817

40670

2.34

307.65

6.3

4.5

34.87

36.45

g/l

81.16

6445

38024

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

565

541

10.72

307.65

1.6

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

916

1555

6.17

307.65

1.7

1.4

700.97

3799.49

e6/l

0.68

710

1204

(3033658) Prothrombin time (PT) actual/Normal

4582

24038

2.34

307.65

6.1

3.5

87.88

89.64

5.29

4491

23536

(3027801) Oxygen [Partial pressure] in Arterial blood

2690

9632

3.20

307.65

9.3

8.0

12.87

12.77

kpa

0.40

2607

9248

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

907

1538

6.17

307.65

1.6

1.3

30.34

17.52

e6/l

0.38

654

1119

(3028707) Methadone [Presence] in Urine by Screen method

1132

2461

4.87

307.65

5.3

2.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5747

33048

2.26

307.65

4.9

2.9

64.43

83.19

ng/l

0.26

4223

20819

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3594

12924

3.39

307.65

2.5

2.0

29.21

29.73

5.08

3497

12567

(3020779) Urea [Moles/volume] in Serum or Plasma

2034

7684

2.90

307.65

8.2

6.6

8.18

9.48

mmol/l

13.70

1947

7330

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7839

48439

2.45

307.65

8.3

5.2

11.64

12.16

umol/l

1.72

7473

45823

(3023183) Ammonium ion [Moles/volume] in Plasma

1213

1460

8.92

307.65

3.0

2.4

33.77

33.66

umol/l

0.04

1116

1325

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1769

5077

3.81

307.65

5.2

3.6

24.00

23.95

mmol/l

0.27

1739

5023

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2043

7733

2.90

307.65

2.4

2.2

381.04

385.57

nmol/l

0.33

1900

7159

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

356

310

11.62

307.65

1.2

1.1

—

(3032080) INR in Blood by Coagulation assay

7235

40813

2.64

307.65

14.1

12.8

1.21

1.24

inr

8.83

6266

33532

(3018418) pH of Serum or Plasma

5566

25677

2.96

307.65

4.9

3.6

7.40

1.50

4120

17710

(4198724) Urine methamphetamine measurement

494

512

9.85

307.65

3.4

2.0

—

(3016502) Oxygen saturation in Arterial blood

2315

8598

3.01

307.65

10.0

8.4

95.67

95.77

0.29

2256

8288

(3002032) Base excess in Venous blood by calculation

2528

8201

3.52

307.65

5.3

3.4

1.56

1.55

mmol/l

0.04

2214

7000

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

388

180

21.89

307.65

3.1

29.26

27.90

umol/l

0.78

273

139

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

856

210

42.94

307.65

2.7

2.4

53.92

50.85

umol/l

0.84

771

193

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7906

39824

3.36

307.65

9.2

5.7

1.20

1.21

mmol/l

52.66

7601

36667

(3026008) Bacteria identified in Urine by Culture

4564

25918

2.12

307.65

3.8

2.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1535

4676

3.53

307.65

2.4

1.6

0.38

0.28

mg/l

9.59

918

2207

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2690

9633

3.20

307.65

9.3

8.0

5.09

kpa

0.03

2611

9250

(3020191) Ethanol [Moles/volume] in Serum or Plasma

722

734

10.21

307.65

2.2

1.2

1.18

1.44

promille

2.89

581

586

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2462

8588

3.24

307.65

2.2

1.6

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5057

28613

2.20

307.65

3.6

2.3

57.34

65.63

u/l

2.10

4740

26406

(3019977) pH of Arterial blood

2705

9635

3.22

307.65

9.4

8.0

7.41

0.04

1520

4990

(3024354) Oxygen [Partial pressure] in Venous blood

2212

7065

3.51

307.65

4.7

2.8

4.71

4.65

kpa

0.63

2141

6864

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5638

33534

2.14

307.65

4.5

3.0

37.64

32.48

u/l

2.20

5329

31665

(3026782) Osmolality of Urine

3544

17007

2.44

307.65

3.3

2.6

517.60

558.18

mosm/kgh2o

19.70

3151

14801

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1607

2501

7.08

307.65

2.4

2.3

432.92

871.59

ug/l

2.31

1547

2343

(3023368) Bacteria identified in Blood by Culture

5074

22629

2.96

307.65

5.7

3.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1507

993

16.77

307.65

5.2

5.5

367.02

370.56

umol/l

0.25

1356

847

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

945

1522

6.52

307.65

1.5

1.2

3.85

3.75

mmol/l

1.55

882

1448

(3000991) Gas panel - Venous blood

2319

7616

3.43

307.65

10.4

8.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3280

16221

2.32

307.65

4.7

3.2

246.80

690.29

ng/l

6.82

2486

12102

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2590

8406

3.53

307.65

5.3

3.4

5.86

5.79

kpa

2.36

2513

8196

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2089

5975

3.91

307.65

9.3

8.4

24.49

24.62

mmol/l

0.84

2076

5943

(3013650) Neutrophils [#/volume] in Blood by Automated count

8141

57284

2.03

307.65

14.1

8.0

4.26

4.10

e9/l

6.90

7062

48979

(3013826) Glucose [Moles/volume] in Serum or Plasma

9212

56611

2.96

307.65

8.2

4.3

6.66

6.67

mmol/l

0.17

8890

52536

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1026

1745

6.21

307.65

1.6

1.3

489.18

515.38

mg/l

0.74

984

1672

(3044290) Cell count panel - Cerebral spinal fluid

880

1452

6.34

307.65

1.7

1.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8482

44764

3.39

307.65

9.9

6.1

1.20

1.21

mmol/l

62.63

7580

38468

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1594

5838

2.93

307.08

5.1

3.5

5.19

5.11

kpa

2.86

1525

5561

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

193

35.79

305.68

3.4

3.8

42.22

37.35

umol/l

0.97

173

(3022096) Basophils/Leukocytes in Blood

6916

46721

1.96

304.09

8.5

5.9

0.64

0.68

10.31

6548

43609

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4277

24434

2.07

303.95

2.6

2.2

2.79

2.71

mg/l

1.49

3694

21031

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1433

4989

3.06

301.98

5.0

3.4

1.55

mmol/l

0.00

1036

3546

(36304419) Bacteria [Presence] in Urine

4350

25135

2.05

298.64

4.0

2.8

3504.45

364.71

estimate

0.43

110

(3023410) Appearance of Cerebral spinal fluid

472

701

6.86

297.18

1.9

1.5

—

(3009343) pH of Capillary blood

1552

5704

2.91

296.61

5.1

3.5

7.41

4.21

1349

4625

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

394

489

8.17

290.64

1.4

1.2

2.11

2.05

mmol/l

0.33

355

462

(3004119) Hemoglobin [Mass/volume] in Venous blood

1416

5004

3.01

290.18

4.4

3.0

129.37

131.88

g/l

3.51

1378

4872

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1213

3924

3.26

289.10

1.6

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

3678

20173

2.10

289.04

3.3

2.4

6.23

5.17

e6/l

4.56

3400

18193

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

9844

75786

2.08

288.84

10.6

6.6

82.91

77.73

u/l

17.08

9446

71530

(3002030) Lymphocytes/Leukocytes in Blood

7058

48634

1.92

285.66

8.4

5.7

27.27

28.89

28.04

6747

46018

(3028271) Lactate [Moles/volume] in Capillary blood

576

1085

5.43

284.69

2.4

1.7

2.13

1.73

mmol/l

6.40

557

1048

(3021960) Folate [Moles/volume] in Serum or Plasma

4326

25303

2.02

284.25

1.9

1.6

18.66

19.93

nmol/l

7.31

3839

21514

(3018010) Neutrophils/Leukocytes in Blood

6910

47706

1.89

273.48

8.3

5.6

57.39

56.48

7.98

6662

45513

(3018095) Leukocytes [#/volume] in Urine

5610

36280

1.91

271.12

5.1

3.4

76.30

85.91

e6/l

0.46

4168

24036

(3031040) Bacteria [#/volume] in Urine by Automated count

8754

65480

1.93

267.91

6.0

3.7

2961.00

1546.08

e6/l

0.88

130

926

(3011288) Drugs identified in Urine by Screen method Nominal

1325

4760

2.94

262.62

7.0

2.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

304

308

9.95

262.43

1.7

1.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

866

2407

3.73

260.66

5.7

3.7

8.78

8.63

kpa

1.30

838

2344

(3015377) Calcium [Moles/volume] in Serum or Plasma

4905

30724

1.91

258.02

4.0

3.0

2.34

2.36

mmol/l

16.99

4493

27933

(3012501) Base excess in Blood by calculation

668

1549

4.43

257.66

4.6

3.7

2.25

2.41

mmol/l

0.65

458

1009

(3013290) Carbon dioxide [Partial pressure] in Blood

668

1550

4.43

257.45

4.6

3.7

5.04

4.98

kpa

1.33

656

1520

(3027315) Oxygen [Partial pressure] in Blood

669

1557

4.41

256.83

4.6

3.7

8.69

8.84

kpa

1.21

657

1526

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

348

444

7.92

250.69

1.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1919

8512

2.43

248.78

3.4

2.2

35.96

56.55

u/l

1.29

1634

7195

(1001926) Buprenorphine [Presence] in Urine by Screen method

1419

5527

2.72

240.67

4.8

1.8

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1328

5037

2.78

236.97

11.1

10.0

16.04

16.26

1.91

1296

4848

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1382

5380

2.71

234.38

1.8

1.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2686

14013

2.12

234.27

3.0

2.3

2.28

2.38

g/l

13.14

2465

12917

(3022948) Iron [Moles/volume] in Serum or Plasma

2846

15193

2.08

233.40

3.0

2.4

12.44

13.90

umol/l

19.35

2644

14178

(3010421) pH of Blood

830

2434

3.52

229.98

4.5

3.4

7.41

0.84

818

2406

(3044640) Blood type and Crossmatch panel - Blood

4892

31545

1.84

227.81

3.0

2.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

395

646

6.19

226.19

18.6

15.6

2098.04

2803.12

nmol/l

0.11

389

629

(40767503) Oxygen content in Capillary blood by calculation

628

1540

4.18

224.79

3.1

2.4

16.86

16.90

0.11

610

1501

(1616796) Gas panel - Central venous blood

659

1696

3.98

220.81

4.3

3.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2478

12793

2.12

220.77

3.1

2.4

22.32

23.54

3.29

2300

11891

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6031

41694

1.78

220.40

2.4

1.9

92.67

96.37

pmol/l

8.13

3488

22309

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

438

816

5.45

218.72

1.1

—

14.21

—

(3027945) Reticulocytes/Erythrocytes in Blood

2019

9665

2.25

217.30

3.1

2.4

1.86

1.70

8.44

1805

8592

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

298

378

7.94

215.63

3.4

2.0

152.11

150.15

umol/l

0.02

149

190

(40758558) Short blood count panel - Blood

4563

29393

1.81

208.85

9.0

5.2

—

(3016879) Cocaine [Presence] in Urine

1542

6691

2.44

207.60

4.9

1.8

—

(3022806) Fractional oxyhemoglobin in Capillary blood

428

820

5.29

207.14

2.3

1.6

89.58

89.79

0.25

414

807

(3024928) Oxygen saturation in Venous blood

727

2106

3.55

204.85

3.7

3.0

61.64

63.19

0.95

684

2050

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2100

10467

2.16

203.38

3.2

2.4

9.32

8.59

umol/l

0.56

1771

9173

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1930

9334

2.22

201.46

3.8

4.0

240.20

239.79

u/l

0.04

1820

8840

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1253

5012

2.62

200.02

8.9

6.6

24.38

24.34

mmol/l

0.11

1210

4779

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3266

19164

1.90

199.97

2.2

1.6

1.39

1.25

mg/l

1.20

2542

14453

(3000764) Benzodiazepines [Presence] in Urine

1596

7163

2.36

198.77

4.8

1.8

—

(3028300) Cannabinoids [Presence] in Urine

1600

7247

2.34

194.91

4.9

1.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2714

15095

1.97

194.19

3.7

2.7

3.57

2.42

e6/l

4.56

1354

6965

(3027008) Opiates [Presence] in Urine

1594

7228

2.34

193.60

4.5

1.7

—

(3021589) Normoblasts [#/volume] in Blood

6406

46155

1.71

193.24

15.0

9.2

0.00

e9/l

0.25

5215

37342

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3821

23803

1.82

192.11

2.9

2.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

2137

10958

2.10

191.27

2.0

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

674

1955

3.53

189.33

1.4

1.2

—

(3042936) Bacteria identified in Isolate by Culture

2367

12655

2.03

188.93

2.4

1.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

830

2750

3.11

187.96

4.2

2.8

24.55

24.51

mmol/l

0.11

811

2694

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1032

3870

2.77

186.70

5.5

3.4

50.31

47.67

2.67

1020

3805

(3027273) Bicarbonate [Moles/volume] in Venous blood

963

3504

2.85

184.38

4.6

3.0

25.19

24.97

mmol/l

1.15

925

3385

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

204

194

10.53

184.06

1.3

1.1

—

(3020891) Body temperature

996

3705

2.79

182.88

6.2

4.1

36.95

36.90

°c

3.03

986

3672

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

536

1375

3.97

180.03

1.5

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

536

1375

3.97

180.03

1.5

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2829

16316

1.90

179.99

3.6

2.6

1.16

1.01

e6/l

1.12

1487

8241

(3008295) Osmolality of Serum or Plasma

403

842

4.84

176.30

1.5

1.6

275.81

282.35

mosm/kgh2o

4.29

306

650

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2850

16595

1.88

175.49

3.1

2.7

2.44

mmol/l

0.27

2512

14774

(3027944) Amphetamines [Presence] in Urine

1539

7175

2.26

174.06

4.5

1.7

—

(3036489) Thrombin time

931

3451

2.79

171.83

2.7

2.0

21.00

20.90

0.19

857

3026

(3021901) Oxygen saturation in Capillary blood

557

1542

3.68

167.61

4.0

2.9

90.56

90.29

0.40

539

1496

(3016038) Potassium [Moles/volume] in Urine

285

454

6.31

167.38

1.3

1.5

29.06

36.68

mmol/l

5.55

237

406

(3037467) Urinalysis macro (dipstick) panel - Urine

8718

69720

1.68

164.80

5.5

3.8

2.18

2.64

—

105

(3023520) Reticulocytes [#/volume] in Blood

1520

7223

2.22

163.55

2.8

2.4

71.68

68.57

e9/l

2.11

1068

5183

(3042517) Benzodiazepines panel - Urine

149

105

14.16

162.14

3.8

1.9

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

750

2593

2.97

157.13

2.2

1.8

2.48

2.14

ug/l

0.35

649

2298

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

364

769

4.78

157.07

1.1

1.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1392

6507

2.24

155.53

2.6

2.0

6.81

8.67

ug/l

3.00

1208

5768

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1719

8786

2.07

152.61

4.9

2.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3693

24095

1.71

151.16

3.2

2.9

1509.30

1300.42

ng/l

1.64

3160

20347

(3005719) IgG [Mass/volume] in Serum or Plasma

1396

6610

2.21

150.93

2.7

2.6

10.60

10.76

g/l

0.64

1266

6072

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

9073

74072

1.65

150.52

5.5

2.9

65.46

42.25

u/l

55.42

8737

70023

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6317

47342

1.60

148.36

3.3

2.5

—

estimate

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

158

144

10.95

146.72

1.2

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1366

6517

2.19

144.64

4.8

3.3

1.21

1.23

mmol/l

17.67

1242

5499

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

904

3625

2.57

142.07

1.9

1.7

1.47

g/l

0.02

782

3103

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

159

154

10.31

141.60

1.2

1.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

699

2472

2.89

140.30

5.1

3.9

1.56

1.43

mmol/l

1.53

683

2434

(3019550) Sodium [Moles/volume] in Serum or Plasma

11844

105089

2.00

137.61

30.6

13.2

138.71

139.75

mmol/l

252.89

11718

102519

(3020630) Protein [Mass/volume] in Serum or Plasma

1305

6234

2.18

137.41

2.0

2.4

65.61

66.95

g/l

6.88

1201

5702

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

891

3617

2.53

136.35

6.6

4.7

1.85

1.63

5.06

852

3404

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

152

147

10.32

135.50

1.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5894

44254

1.56

131.68

2.9

2.3

72.17

74.98

nmol/l

10.48

5408

40516

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

205

300

6.84

130.58

1.1

—

0.11

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

11836

105368

1.97

130.45

30.3

13.4

3.95

3.96

mmol/l

8.03

11693

102545

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

530

1683

3.20

128.29

1.7

1.4

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

114

14.74

126.95

1.7

1.2

—

mmol/l

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

841

3455

2.50

125.24

5.8

3.6

24.47

24.65

mmol/l

1.02

806

3211

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

540

1782

3.08

122.40

1.7

1.4

—

(3022313) Gas panel - Capillary blood

960

4246

2.33

121.21

5.7

3.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

810

3320

2.50

121.13

6.8

4.9

0.86

0.90

1.65

775

3118

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

293

643

4.58

120.62

1.4

1.5

—

(3015736) pH of Urine

5755

43573

1.53

119.99

4.1

2.9

6.36

6.19

23.58

3069

24200

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

308

708

4.37

119.58

2.0

1.4

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

252

500

5.05

117.04

2.0

1.5

2996582.00

1538085.22

iu/ml

0.84

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

212

365

5.81

115.04

2.4

141.81

154.02

nmol/l

0.72

186

321

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

342

892

3.86

111.96

5.9

6.0

11.07

11.11

mg/l

0.05

309

830

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

333

860

3.90

110.54

4.5

1.9

—

(3043409) Potassium [Moles/volume] in Arterial blood

574

2073

2.81

110.47

5.6

4.2

3.82

3.91

mmol/l

3.88

567

2062

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

8882

74436

1.53

110.44

4.6

3.7

12.79

10.23

mm/h

43.30

8358

69520

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

202

347

5.82

109.88

1.4

1.3

51.27

68.84

1.38

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

639

2446

2.66

109.86

3.6

3.2

0.33

0.34

iu/ml

0.47

355

1279

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

138

156

8.82

109.59

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

14.76

109.28

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

11780

105941

1.84

107.89

25.8

11.1

24.35

24.54

mg/l

0.26

10422

83364

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

706

2864

2.51

107.69

3.5

2.4

3.41

3.56

g/l

1.90

686

2736

(3035350) Ketones [Presence] in Urine by Test strip

6860

54789

1.49

105.32

4.6

3.2

12.49

2.87

estimate

2.43

1586

10852

(3052851) Hemolysis interference index of Serum or Plasma

607

2320

2.66

104.61

3.7

2.9

2.90

2.26

index

0.89

364

1148

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

16.95

104.19

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2239

13934

1.70

103.55

1.9

1.6

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

259

585

4.44

102.83

15.3

12.8

0.61

mmol/l

0.13

240

538

(3028026) IgM [Mass/volume] in Serum or Plasma

1054

5172

2.10

102.37

1.8

1.9

1.32

1.30

g/l

0.08

973

4757

(3009261) Glucose [Presence] in Urine by Test strip

6874

55124

1.48

102.03

4.6

3.2

2.03

0.24

estimate

0.91

1491

10274

(3021601) Nitrite [Presence] in Urine by Test strip

6765

54149

1.47

100.90

4.6

3.2

0.00

estimate

3.28

1560

10691

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

448

1514

2.99

97.25

6.1

5.6

471.82

601.08

iu/ml

0.24

212

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

278

697

4.00

96.16

1.2

1.1

35.26

44.57

mg/l

3.51

229

589

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

364

1100

3.33

95.40

4.2

2.8

1426.61

584.10

u/ml

0.43

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6379

50896

1.46

94.06

3.7

2.9

131.43

109.81

ug/l

4.87

5934

47843

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1174

6177

1.96

93.63

4.8

3.8

88.33

86.09

ng/l

0.32

1036

5397

(3047181) Lactate [Moles/volume] in Blood

614

2493

2.50

93.30

7.6

5.4

1.49

1.27

mmol/l

3.27

544

2184

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

13.45

93.15

1.2

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

352

1067

3.32

91.80

1.8

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

3107

21520

1.55

91.52

1.6

1.4

2.43

2.31

g/l

2.37

1868

13398

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

695

3013

2.35

91.34

3.2

2.3

91.00

92.78

1.03

677

2914

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

654

2771

2.40

90.52

3.8

2.4

192.00

184.17

1.35

629

2638

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

130

174

7.44

89.79

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

459

1643

2.82

89.69

1.6

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

169

299

5.64

89.15

1.1

66.45

251.29

ng/l

1.23

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

9334

80477

1.48

89.09

4.9

3.9

14.51

14.67

pmol/l

7.73

8643

73555

(3000570) Elastase.pancreatic [Mass/mass] in Stool

570

2288

2.53

88.69

1.5

1.4

247.19

279.10

ug/g

2.58

335

1299

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

263

677

3.89

87.70

1.1

233.26

268.21

mg/l

2.22

229

613

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

242

588

4.12

87.36

1.4

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

642

2744

2.38

87.09

2.0

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

567

2303

2.49

86.02

1.8

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

3395

24266

1.51

85.46

4.1

3.2

0.14

0.43

0.65

239

(3009508) Creatinine [Moles/volume] in Urine

4652

35401

1.46

85.45

4.9

3.4

7.53

8.27

mmol/l

19.18

4029

30385

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

252

645

3.91

84.71

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

13.24

83.92

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

320

970

3.31

83.45

7.5

12.1

7.02

7.44

mmol/l

1.18

273

781

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

288

819

3.53

83.01

1.8

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

518

2057

2.55

82.39

2.6

2.1

130.46

132.71

g/l

1.36

435

1570

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2743

18855

1.55

82.30

1.8

1.6

12965855.07

33394940.30

pmol/l

2.04

2283

15799

(44790049) Parainfluenza type 3 nucleic acid detection

305

906

3.38

82.15

1.6

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

305

906

3.38

82.15

1.6

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

305

907

3.37

82.01

1.6

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

305

907

3.37

82.01

1.6

1.4

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

219

526

4.16

80.31

1.3

1.2

0.56

0.71

ratio

3.22

121

313

(40768797) Stomach Pathology biopsy report

1885

11957

1.65

79.05

1.3

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

284

839

3.39

77.17

1.8

1.4

—

(3007463) Buprenorphine [Presence] in Urine

16.71

76.09

5.0

4.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

433

1645

2.65

75.35

1.5

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

15.73

74.96

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

3491

25641

1.47

74.90

2.3

2.1

—

(3019225) pH of Specimen

1349

7937

1.75

74.53

4.6

3.4

7.37

7.35

6.00

1183

5464

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

546

2328

2.37

74.35

2.0

1.6

0.22

0.23

g/l

1.03

508

2227

(3037522) Nuclear Ab [Titer] in Serum

1950

12696

1.60

73.08

1.4

1.3

343.15

525.15

titre

10.48

375

2469

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

557

2415

2.33

72.99

2.0

1.6

1.16

1.18

g/l

0.61

523

2316

(3044889) 12 lead EKG panel

8135

69546

1.40

72.08

4.4

3.5

0.50

5699.57

—

134

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3431

25295

1.46

71.58

1.5

1.4

2.17

1.91

u/ml

0.38

847

6897

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

126

7.81

71.43

1.3

1.2

—

(3017181) Myelocytes/Leukocytes in Blood

1340

7980

1.73

70.74

5.0

4.2

0.96

0.89

0.38

499

1992

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

363

1304

2.80

70.41

1.6

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

646

3029

2.16

70.01

2.1

1.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1103

6246

1.81

69.20

3.2

2.7

208.24

182.91

ng/l

0.98

995

5658

(3002179) Metamyelocytes/Leukocytes in Blood

1281

7617

1.73

67.86

4.6

4.0

0.72

0.64

0.34

470

1909

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

113

7.82

64.36

1.1

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

371

1414

2.64

64.13

1.5

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

677

3351

2.05

63.53

1.4

1.6

4.94

13.17

iu/ml

2.78

108

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

299

1024

2.93

63.36

1.6

1.3

—

(21494755) Public health laboratory ask at order entry panel

720

13042

0.52

63.35

1.3

—

(3039000) Anion gap in Blood by calculation

419

1714

2.46

62.49

9.1

6.4

11.46

11.37

mmol/l

0.15

388

1523

(3018572) Chloride [Moles/volume] in Blood

419

1715

2.46

62.41

9.2

6.4

103.93

105.33

mmol/l

4.98

388

1525

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1071

6218

1.76

61.48

2.3

20.70

19.88

au/ml

0.14

767

(3025159) Blasts/Leukocytes in Blood

1287

7865

1.68

61.34

5.2

4.3

0.10

0.31

1.57

400

1660

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

119

216

5.48

61.15

1.4

1.2

23.69

16.93

0.35

(3021440) Promyelocytes/Leukocytes in Blood

1265

7703

1.69

61.10

5.1

4.2

0.12

0.10

0.31

426

1724

(3016650) Hepatitis A virus Ab [Presence] in Serum

407

1664

2.46

60.77

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

874

14776

0.55

60.71

1.8

3.48

3.55

ratio

0.72

645

11076

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

10703

97105

1.45

59.62

6.1

4.6

1.87

1.88

mu/l

0.45

10085

90195

(3019150) Specific gravity of Urine by Refractometry

3270

24597

1.41

59.01

4.9

3.3

1.02

1.21

kg/l

1.09

2260

15583

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

997

5741

1.77

58.79

1.3

58.69

54.44

au/ml

0.16

389

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2822

20743

1.44

57.73

1.9

1.7

—

(3029937) Albumin [Presence] in Urine by Test strip

3756

29038

1.39

57.36

4.9

3.3

0.00

estimate

0.18

1429

9800

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

596

2939

2.05

56.44

1.8

2.2

3.83

3.72

g/l

0.85

550

2696

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

573

2789

2.07

56.20

1.8

2.2

3.04

2.80

g/l

6.28

527

2542

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

596

2948

2.04

55.96

1.8

2.2

4.17

4.24

g/l

1.33

551

2704

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

596

2954

2.04

55.65

1.8

2.2

7.51

7.22

g/l

3.28

550

2707

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

378

1569

2.42

54.61

1.8

1.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1185

7306

1.66

54.29

3.0

2.2

0.51

0.39

e6/l

0.76

1145

6982

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

583

2895

2.03

54.14

1.2

1.3

—

(3008037) Lactate [Moles/volume] in Venous blood

430

1907

2.27

53.36

4.3

2.5

1.78

1.61

mmol/l

1.79

419

1853

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

9.61

52.75

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

544

2665

2.06

52.41

1.2

1.3

86.62

124.87

titre

0.67

275

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

603

3069

1.98

52.24

7.0

3.5

1.53

1.39

mg/l

3.69

562

2798

(3023511) Choriogonadotropin [Units/volume] in Urine

526

2562

2.07

51.47

1.6

1.3

—

(3000494) Fungus identified in Specimen by Culture

1718

11714

1.51

50.90

1.6

1.4

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

633

11191

0.54

50.60

1.6

3.39

3.46

mmol/l

0.72

414

7460

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

450

2078

2.18

50.58

1.8

2.2

0.00

g/l

0.78

398

1832

(4035726) Immunohistochemistry procedure

1149

7154

1.64

50.50

1.5

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

517

2523

2.06

50.32

1.8

2.2

10.14

10.27

g/l

0.24

468

2253

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

532

2624

2.04

50.31

2.5

2.7

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

178

514

3.45

50.23

1.0

283.47

332.49

ng/l

1.67

137

378

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

178

516

3.44

49.93

1.0

723.25

772.08

ng/l

0.61

129

368

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

472

2237

2.12

49.64

1.3

1.5

11.78

11.71

iu/ml

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

444

2060

2.17

49.32

1.4

1.2

35.78

37.61

u/ml

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

177

518

3.41

48.93

1.0

36.05

42.50

ng/l

1.52

131

376

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

460

2172

2.13

48.85

1.8

2.2

0.01

g/l

0.03

420

1961

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

8.54

48.24

1.1

1.0

—

(40761536) Microorganisms panel - Urine sediment

1236

7937

1.59

47.75

5.2

3.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

8.42

47.72

1.1

1.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

423

1951

2.18

47.69

1.8

2.2

0.00

g/l

-0.00

396

1827

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

376

1655

2.28

47.51

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

418

1933

2.17

46.82

1.4

1.3

244.06

240.95

u/ml

0.08

242

1176

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

944

5699

1.68

46.64

3.1

3.6

4.45

4.62

pmol/l

5.59

855

5163

(3048929) Epstein Barr virus Ab [Presence] in Serum

712

3975

1.81

46.36

1.4

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

490

2421

2.04

46.10

2.3

3.1

52.09

44.99

mg/l

0.36

410

2052

(3021387) Prolactin [Units/volume] in Serum or Plasma

819

4775

1.74

45.96

1.8

1.7

376.76

298.58

mu/l

4.43

725

4360

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

165

481

3.42

45.91

1.8

1.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

490

2425

2.03

45.89

2.3

3.1

56.81

56.31

mg/l

0.03

410

2055

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

511

2571

2.00

45.70

1.8

2.3

0.59

0.88

g/l

1.51

454

2218

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

16.09

45.43

1.1

1.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

393

1804

2.19

44.85

1.6

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

393

1804

2.19

44.85

1.6

1.4

21.89

20.91

u/ml

0.06

(3011412) CD3 cells [#/volume] in Blood

205

697

2.93

44.11

2.6

2.4

1308.64

1248.90

e6/l

0.36

168

607

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

374

1699

2.21

43.80

1.6

1.4

125.00

142.68

au/ml

1.70

100

503

(36660697) Celiac disease serology panel - Serum

1325

8811

1.54

43.71

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

613

3330

1.86

43.58

1.7

1.8

40.43

39.53

u/l

0.46

553

2980

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

475

2374

2.01

43.29

1.3

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

157

461

3.39

43.22

1.1

1.02

1.07

u/l

0.46

177

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

871

5276

1.67

42.39

1.2

1.1

1.29

15.89

u/ml

0.98

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

10030

91519

1.33

41.95

32.2

14.3

13.68

13.42

64.10

9955

90068

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

168

526

3.18

41.71

2.8

2.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

3008

23397

1.35

41.63

5.9

4.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.29

41.60

1.1

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

704

4054

1.75

41.20

1.5

1.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

235

897

2.62

40.60

2.4

2.9

20.38

20.71

nmol/l

0.14

218

861

(3034770) Mitochondria Ab [Titer] in Serum

500

2603

1.93

40.50

1.2

1.3

501.25

966.94

titre

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

892

5500

1.64

40.47

2.7

2.4

8549.52

6830.70

u/l

0.65

310

2237

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

433

2148

2.02

40.29

2.3

3.1

2.35

5.13

ratio

0.90

234

1179

(3044242) Glucose [Moles/volume] in Arterial blood

138

392

3.50

40.02

2.2

2.0

7.96

8.21

mmol/l

0.29

138

392

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

10753

99333

1.35

39.92

23.4

11.3

89.38

85.87

ml/min/173m2

44.76

9969

89709

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

645

3664

1.78

39.55

2.4

1.9

—

(3014051) Protein [Presence] in Urine by Test strip

3715

29969

1.31

39.48

3.3

2.5

0.03

0.07

0.71

616

(40757494) Bilirubin.total [Moles/volume] in Blood

127

348

3.63

38.89

2.2

2.6

44.36

64.91

umol/l

0.47

(3037121) Protein [Mass/volume] in Urine

558

3051

1.84

38.83

3.5

3.4

439.37

407.56

mg/l

0.16

322

1430

(3024891) Influenza virus A+B Ag [Presence] in Specimen

515

2755

1.88

38.40

1.3

1.1

—

(3011985) Renin [Units/volume] in Plasma

298

1311

2.27

37.76

1.8

1.5

57.95

72.31

mu/l

0.66

269

1192

(3004809) Band form neutrophils/Leukocytes in Blood

279

1201

2.32

37.20

3.5

3.1

1.53

1.48

0.06

255

1053

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

165

553

2.97

36.50

2.7

2.0

11.65

15.02

5.05

159

542

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4897

41257

1.27

36.34

4.7

3.1

0.24

0.12

estimate

0.37

1320

8817

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

559

3121

1.80

36.32

1.4

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

339

1596

2.13

36.31

1.6

1.5

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

9.90

35.67

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

158

524

3.00

35.62

2.4

2.6

534.88

512.59

e6/l

0.25

117

422

(3000093) Morphology [Interpretation] in Blood Narrative

209

804

2.59

35.59

1.2

1.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

163

552

2.94

35.41

2.8

2.2

92.48

97.29

0.88

158

514

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

159

534

2.96

35.06

2.4

2.7

212.50

242.51

e6/l

1.01

121

451

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

241

4.04

35.02

4.7

2.7

4.96

4.98

kpa

0.05

241

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

242

4.02

34.83

4.7

2.7

10.49

10.45

kpa

0.03

242

(3026250) Tacrolimus [Mass/volume] in Blood

122

351

3.45

34.75

44.1

38.4

6.84

7.30

ug/l

1.74

116

321

(1175426) CD3 cells/Lymphocytes in Blood

167

580

2.87

34.67

2.7

2.1

73.97

71.48

1.12

160

560

(3015171) Extractable nuclear Ab [Units/volume] in Serum

562

3187

1.77

34.64

1.2

0.49

0.88

u/ml

0.91

233

(3037756) Immunofixation for Serum or Plasma

307

1418

2.16

34.55

1.3

1.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

106

280

3.76

34.29

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

147

484

3.02

33.59

1.3

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

147

484

3.02

33.59

1.3

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

147

484

3.02

33.59

1.3

1.4

—

(3017569) Oxygen content in Arterial blood

126

379

3.30

33.48

2.4

2.3

16.21

16.32

0.12

126

379

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1504

10783

1.43

33.45

10.2

5.5

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

112

313

3.55

33.37

2.6

2.1

29.16

27.09

0.82

106

303

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

190

722

2.62

33.20

2.6

2.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

268

1204

2.22

32.34

1.3

1.4

713.23

327.49

pmol/l

0.50

224

1032

(3006245) CD3-CD19+ cells/cells in Blood

116

339

3.40

32.28

2.8

2.3

12.20

10.85

0.37

109

323

(3024980) IgG subclass 4 [Mass/volume] in Serum

309

1472

2.10

32.14

1.4

1.6

0.64

0.82

g/l

3.47

239

1152

(3023420) DNA double strand Ab [Units/volume] in Serum

606

3588

1.70

32.03

2.0

1.7

8.48

6.36

iu/ml

0.73

134

832

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

309

1479

2.09

31.74

1.4

1.2

4.01

3.93

u/ml

0.04

150

707

(3020564) Creatinine [Moles/volume] in Serum or Plasma

11960

113270

1.41

30.93

30.5

14.7

76.25

76.91

umol/l

1.00

11872

111718

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

129

414

3.10

30.84

1.3

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

185

722

2.55

30.65

3.4

3.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

314

1541

2.04

30.16

1.4

1.2

3.70

3.19

u/ml

0.22

131

573

(3017732) Neutrophils [#/volume] in Blood

1641

12163

1.38

29.82

4.3

2.9

4.29

4.48

e9/l

1.02

1440

10613

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

244

1092

2.23

29.75

1.3

0.59

3.74

nmol/l

0.99

234

1053

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

125

408

3.04

29.06

1.4

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

269

1266

2.12

28.92

1.2

1.1

0.31

0.95

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

245

1112

2.20

28.87

1.3

0.18

0.21

nmol/l

0.24

(3000060) B lymphocytes [#/volume] in Blood

260

3.59

28.50

2.6

2.1

0.72

0.60

e9/l

0.09

128

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

168

649

2.58

28.46

1.3

81.55

80.03

0.08

(3038515) Glucose [Moles/volume] in Venous blood

321

1629

1.97

28.09

4.6

2.5

7.35

7.77

mmol/l

1.56

313

1588

(3025941) Bacteria identified in Stool by Culture

806

5281

1.54

28.07

1.3

1.2

—

(3028433) Virus identified in Specimen by Culture

209

3.89

27.98

1.3

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

214

931

2.29

27.95

1.3

—

nmol/l

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

256

5011

0.49

27.75

1.1

0.57

0.63

ratio

0.82

570

(42529406) Shigella sp [Presence] in Stool by Culture

443

2515

1.76

27.22

1.3

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

375

2026

1.85

27.16

1.9

2.0

10.44

10.85

mg/l

0.53

350

1913

(3014765) Yersinia sp identified in Stool by Organism specific culture

440

2503

1.76

26.85

1.3

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

271

3.44

26.79

3.0

2.5

0.59

0.62

mmol/l

2.46

271

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

438

2492

1.76

26.72

1.3

1.1

—

(3017509) Phencyclidine [Presence] in Urine

137

4.56

26.47

3.0

1.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1162

8289

1.42

26.29

4.0

4.3

11.33

30.90

ug/l

3.22

961

6680

(3034988) Calcium [Moles/volume] in Capillary blood

154

4.31

26.26

2.5

2.2

1.17

1.19

mmol/l

1.35

142

(3027135) IgG subclass 1 [Mass/volume] in Serum

204

894

2.27

26.22

1.4

1.3

6.83

6.67

g/l

0.27

149

633

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11877

112811

1.36

26.04

16.3

9.5

28.43

27.30

u/l

3.54

11645

109453

(3028192) IgG subclass 2 [Mass/volume] in Serum

203

894

2.26

25.79

1.4

1.3

2.74

3.06

g/l

1.54

149

633

(3024139) IgG subclass 3 [Mass/volume] in Serum

203

894

2.26

25.79

1.4

1.3

0.39

0.41

g/l

0.42

145

632

(3051611) Lipemic interference index of Serum or Plasma

193

832

2.31

25.79

4.1

2.9

13.81

13.49

index

0.13

149

456

(3000012) Reticulocyte production index

232

1081

2.14

25.64

2.2

1.9

0.95

0.88

0.81

175

687

(3003434) Protein [Mass/volume] in Pleural fluid

231

1079

2.13

25.38

1.5

33.68

33.75

g/l

0.03

209

972

(3028308) Erythrocytes [#/volume] in Pleural fluid

194

845

2.29

25.31

1.5

1.4

67750.68

51866.16

e6/l

0.33

114

468

(3048689) Calprotectin [Mass/mass] in Stool

1807

13922

1.33

25.16

2.5

2.7

132.05

125.79

ug/g

0.30

1444

11145

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

209

944

2.20

24.99

1.3

0.19

0.21

nmol/l

0.58

163

760

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

101

319

3.14

24.90

2.7

2.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

209

949

2.19

24.67

1.5

1.4

11238.28

3473.10

e6/l

0.82

144

659

(3028679) Herpes simplex virus Ab [Presence] in Serum

151

597

2.51

24.45

1.2

—

(4062490) Immunoglobulin typing, IgG

196

873

2.23

24.27

1.5

1.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

6.91

24.14

1.1

1.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

107

356

2.98

24.14

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

107

356

2.98

24.14

1.4

1.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

305

3.16

24.10

30.6

25.8

111.70

122.48

ug/l

0.63

254

(3009214) Lutropin [Units/volume] in Serum or Plasma

629

4035

1.57

24.06

1.6

1.5

9.00

8.04

u/l

1.06

477

3204

(3022493) Free Hemoglobin [Mass/volume] in Plasma

111

380

2.90

23.80

3.3

4.2

1348.50

1677.99

mg/l

0.08

270

(3032352) Blasts [#/volume] in Cerebral spinal fluid

6.60

23.77

3.1

2.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

118

421

2.78

23.46

1.3

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

440

2605

1.69

23.29

1.2

1.1

5.31

4.03

0.81

435

(3041354) Potassium [Moles/volume] in Venous blood

183

814

2.24

22.76

3.1

1.9

4.07

4.08

mmol/l

0.23

183

807

(3035285) Chloride [Moles/volume] in Venous blood

183

814

2.24

22.76

3.1

1.9

104.63

105.55

mmol/l

1.37

183

807

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

108

375

2.86

22.60

1.9

1.3

—

(3045414) Leukocytes [Presence] in Urine

1211

8920

1.37

22.55

2.2

1.9

0.01

0.02

estimate

0.45

249

1949

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

272

1408

1.93

22.54

1.2

384.00

327.78

titre

0.11

106

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

186

837

2.21

22.50

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

113

405

2.77

22.29

1.9

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

3551

30075

1.23

22.23

4.2

2.7

0.12

0.15

estimate

0.18

1277

8481

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

173

761

2.26

22.11

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

6.66

22.10

1.1

1.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

271

1413

1.91

21.98

1.1

115.72

114.63

0.21

247

1283

(3017315) Amylase [Enzymatic activity/volume] in Urine

116

425

2.71

21.95

1.4

1.2

253.16

488.51

u/l

1.17

100

388

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

165

715

2.29

21.86

1.2

173.00

198.25

titre

0.15

120

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

474

2910

1.63

21.82

3.3

3.6

1687.14

1478.53

u/ml

0.07

415

2533

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

134

4.21

21.76

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

175

782

2.23

21.55

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

285

3.10

21.50

1.4

1.5

12.71

14.42

pmol/l

2.96

229

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

103

360

2.84

21.32

1.9

1.3

—

(3036180) Methadone [Presence] in Urine

30.78

21.30

4.4

1.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

294

1592

1.84

21.22

1.2

—

(4268621) Lupus anticoagulant assay

221

1098

2.00

20.66

2.4

2.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

3691

31574

1.21

20.58

4.8

4.2

13.57

7.32

mg/mmol

8.07

2442

20207

(4195642) Thrombophilia screening test

267

1417

1.88

20.55

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

175

798

2.18

20.53

3.2

1.9

1.19

1.20

mmol/l

1.10

175

791

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

181

3.61

20.38

4.2

2.2

1.00

1.88

mmol/l

2.44

138

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

18.04

20.20

1.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

923

6616

1.41

20.19

1.4

1.3

366.20

290.04

u/ml

0.73

841

6180

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1010

7355

1.39

20.11

3.3

2.4

70.27

70.95

ml/min/173m2

0.18

444

2870

(3023419) Bacteria identified in Sputum by Culture

207

1017

2.03

19.98

2.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

351

2044

1.71

19.80

2.8

1.9

0.83

0.80

nmol/l

0.32

300

1757

(3012441) Differential panel - Pleural fluid

177

824

2.14

19.72

1.5

—

(40757373) Influenza virus identified in Isolate

132

4.05

19.61

1.5

—

(3045788) Cell count panel - Pleural fluid

173

801

2.15

19.55

1.5

1.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

4.95

19.55

1.3

1.5

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

4.84

19.49

1.7

1.2

51.89

61.96

0.49

(3018133) Calcium [Moles/volume] in Urine

216

3.30

19.40

2.8

2.67

2.64

mmol/l

0.03

199

(3013005) Retinol [Moles/volume] in Serum or Plasma

111

424

2.60

19.40

2.3

2.1

1.79

1.87

umol/l

0.44

105

386

(3001964) Herpes simplex virus Ag [Presence] in Specimen

212

3.32

19.28

1.3

—

(3012516) Albumin [Mass/volume] in Urine

3621

31085

1.21

19.18

4.0

3.5

66.50

45.66

mg/l

5.26

2502

20321

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

199

979

2.02

19.16

1.4

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

280

2.97

18.98

1.3

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

280

2.97

18.98

1.3

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

274

1506

1.81

18.89

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

154

691

2.21

18.84

4.5

3.2

24.55

28.44

mu/l

0.61

137

646

(3017354) Segmented neutrophils/Leukocytes in Blood

164

755

2.16

18.83

3.0

3.1

59.30

55.91

1.29

141

635

(3001019) Free T4 and TSH panel - Serum or Plasma

353

5635

0.61

18.67

1.6

—

(3042631) Mycobacterium sp identified in Specimen

190

931

2.03

18.51

2.2

2.9

—

(3014271) Vancomycin [Susceptibility]

296

2.88

18.37

3.4

2.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

192

953

2.00

18.06

1.4

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

159

738

2.14

17.90

3.7

3.9

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2970

25162

1.21

17.82

3.1

2.4

341.43

346.56

umol/l

1.71

2586

22453

(3020393) Adenovirus Ag [Presence] in Stool

4.48

17.81

1.8

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

112

4.15

17.68

1.1

1.2

65.83

62.06

ug/l

0.47

112

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

163

770

2.10

17.55

1.1

282.85

283.61

mg/l

0.05

147

705

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

6.85

17.50

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.24

17.23

3.3

2.7

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

115

478

2.39

16.87

1.7

1.5

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

158

750

2.09

16.82

1.4

1.3

821.90

524.10

u/l

0.40

148

719

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

131

580

2.24

16.62

1.1

1428.86

1452.03

miu/ml

0.08

131

580

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

401

2529

1.58

16.59

1.3

1.2

19.71

36.61

u/ml

0.80

126

(3024522) Salmonella sp identified in Specimen by Organism specific culture

188

958

1.95

16.45

1.4

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

145

672

2.14

16.43

1.0

1.1

—

0.48

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

126

553

2.26

16.33

1.6

1.4

12.87

12.41

u/l

0.34

120

539

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

204

1073

1.89

16.24

1.1

96.93

97.16

0.04

194

1008

(4024509) Urine culture

609

4214

1.45

16.20

2.2

1.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

984

7379

1.34

16.20

1.3

1.2

113.34

147.50

u/ml

1.48

337

2737

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

221

1194

1.84

16.18

1.3

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

131

589

2.21

16.02

1.3

17.63

14.68

u/l

0.33

120

546

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

108

4.03

15.95

1.7

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

181

921

1.95

15.92

1.4

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

182

929

1.95

15.87

1.4

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

182

929

1.95

15.87

1.4

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

272

2.81

15.75

2.3

1.8

721.42

4247.50

e6/l

0.60

178

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

312

1880

1.65

15.57

1.3

1.2

48.55

42.90

u/ml

0.24

141

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.52

15.53

2.1

2.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

250

2.85

15.21

1.5

1.3

111.60

131.30

nmol/l

0.38

189

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

298

1789

1.66

15.10

1.2

1.1

86.08

6732.69

iu/ml

0.64

403

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

5.65

15.10

1.5

1.1

28.17

11.94

—

(40768806) Pleura Pathology biopsy report

162

810

1.99

15.02

1.5

1.6

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

4.95

14.94

16.4

7.5

0.40

0.33

umol/l

0.46

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

106

450

2.34

14.89

3.8

2.2

150.53

138.11

0.68

424

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

232

2.90

14.84

1.3

1.2

0.28

0.30

g/l

0.94

193

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

373

2378

1.56

14.77

1.3

3.45

4.13

u/ml

0.19

213

(3008116) Ketones [Moles/volume] in Urine by Test strip

186

3.14

14.76

1.8

1.3

0.57

0.25

mmol/l

—

(40768446) Kidney Pathology biopsy report

358

2.49

14.59

2.1

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

251

1454

1.72

14.55

1.8

1.7

481.60

367.77

mu/l

1.38

203

1163

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

534

3680

1.45

14.54

1.6

1.7

19.05

14.39

u/ml

0.43

1011

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

372

2380

1.56

14.51

1.3

4.61

8.20

u/ml

1.50

332

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

279

2.70

14.49

4.4

3.3

0.95

1.10

0.48

279

(3023323) Follitropin [Units/volume] in Serum or Plasma

717

5212

1.38

14.41

1.5

1.4

21.23

22.19

iu/l

0.35

557

4364

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

226

2.89

14.33

2.2

1.7

3222.74

7635.29

e6/l

1.16

113

(3020717) Zinc [Moles/volume] in Serum or Plasma

111

489

2.25

14.32

2.2

1.6

16.53

23.61

umol/l

2.45

104

459

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

273

1626

1.67

14.29

3.2

3.5

278.98

1049.32

u/ml

1.17

252

1475

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

5.33

14.19

5.5

3.5

2.10

2.53

mg/l

0.45

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

140

681

2.04

14.04

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

263

2.71

13.88

1.2

16.30

16.20

umol/l

0.06

226

(3036782) Glucose [Moles/volume] in Pleural fluid

158

808

1.94

13.77

1.3

1.4

6.48

6.12

mmol/l

0.70

145

738

(3024869) Neuronal Ab [Presence] in Serum

125

3.56

13.75

1.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

330

2.49

13.50

1.1

1.2

—

(3013727) Leukocytes other/Leukocytes in Blood

229

2.81

13.42

4.6

3.4

47.62

51.67

0.71

216

(3010838) Calcium [Moles/time] in 24 hour Urine

237

1383

1.70

13.42

1.7

1.9

4.78

5.28

mmol/24h

1.48

207

1234

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

428

2.29

13.38

1.3

1.6

4.02

9.16

nmol/l

0.41

345

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

247

1461

1.68

13.30

1.7

1.9

1714.29

1816.12

titre

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

393

2595

1.51

13.30

2.0

2.1

2.84

3.92

iu/l

2.82

145

1113

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2075

17412

1.21

13.28

2.4

2.2

—

(3044007) Cell count panel - Peritoneal fluid

236

2.77

13.26

1.9

1.8

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

100

437

2.27

13.19

2.8

2.7

41.78

40.02

0.44

226

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

313

1972

1.58

13.09

1.3

1.2

6.47

3.09

u/ml

0.41

125

(3003694) ABO and Rh group [Type] in Blood

3814

33745

1.16

13.05

1.5

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

3.94

13.04

3.2

2.0

1.15

1.34

umol/l

1.99

(3045424) Erythrocytes [Presence] in Urine

623

4503

1.38

12.98

2.2

1.9

0.01

0.19

estimate

0.60

191

1556

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

228

1336

1.70

12.74

1.1

1.58

1.48

g/l

3.56

207

1220

(3042733) HLA Ab [Presence] in Serum

270

2.61

12.68

4.2

4.9

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

162

3.12

12.65

1.2

1.4

22.80

25.78

g/l

0.65

129

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

101

453

2.21

12.54

1.3

1.5

511.85

479.27

mu/l

0.19

436

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

163

3.10

12.53

1.3

1.17

mmol/l

0.17

163

(3006576) Bicarbonate [Moles/volume] in Blood

289

2.54

12.53

5.8

5.9

25.19

24.93

mmol/l

0.21

265

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

17.08

12.39

6.2

6.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

201

2.86

12.38

1.2

1.1

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

102

462

2.19

12.37

1.3

1.5

73.07

72.59

0.19

445

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.93

12.34

2.4

1.9

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

276

1714

1.60

12.30

2.2

2.3

2.22

8.86

titre

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

952

7383

1.29

12.29

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

171

935

1.82

12.17

1.2

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

103

474

2.15

12.02

1.3

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

255

2.60

11.97

1.3

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

123

3.38

11.89

1.9

1.8

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

106

496

2.12

11.86

1.7

1.6

13.09

9.28

ug/l

0.38

457

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

235

1416

1.65

11.84

1.4

1.3

20.17

19.79

u/l

0.07

185

1170

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

446

2.18

11.77

1.3

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

198

1143

1.72

11.72

2.4

2.6

39.54

30.18

iu/ml

0.37

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

134

3.25

11.72

1.1

—

(3024471) HLA-A [Type]

231

2.66

11.57

1.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

171

952

1.78

11.50

1.5

1.3

1.33

1.40

nmol/l

0.36

157

849

(3004716) Salmonella sp identified in Stool by Organism specific culture

754

5728

1.32

11.35

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

185

1058

1.74

11.34

1.2

1.3

31.41

55.66

u/ml

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2203

18833

1.19

11.33

2.6

2.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

165

914

1.79

11.29

1.2

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2021

17158

1.19

11.24

1.3

27.48

34.20

iu/ml

1.45

561

5073

(3024932) HLA-DR beta [Type]

230

2.63

11.14

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

609

7950

0.74

11.13

1.6

1041.23

1004.90

mu/l

0.23

522

6954

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

9.46

11.11

1.1

1.0

—

mmol/l

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1983

22613

0.84

10.80

3.0

3.1

0.71

0.77

ug/l

1.37

1335

13970

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

150

819

1.82

10.79

1.9

1.6

—

(3004451) EKG impression Narrative

379

2.22

10.77

1.4

1.2

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

5.32

10.67

2.0

2.3

209.26

228.22

ug/l

0.19

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

9.44

10.62

5.0

2.9

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

435

2.12

10.47

1.1

0.33

11.02

nmol/l

2.39

100

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

14.00

10.38

1.1

1.0

—

(3044927) Protein electrophoresis panel - Urine

127

668

1.89

10.30

1.2

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

194

1158

1.66

10.21

1.9

1.5

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.21

10.08

1.8

1.7

3.42

1.10

mg/l

0.50

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.21

10.08

1.8

1.7

2.18

1.88

mg/l

0.07

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.21

10.08

1.8

1.7

2.65

2.50

mg/l

0.04

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.21

10.08

1.8

1.7

2.94

1.90

mg/l

0.33

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.21

10.08

1.8

1.7

3.68

4.12

mg/l

0.13

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.21

10.08

1.8

1.7

2.66

0.62

mg/l

0.65

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.21

10.08

1.8

1.7

5.26

3.54

mg/l

0.39

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.21

10.08

1.8

1.7

1.62

1.77

mg/l

0.09

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

4.21

10.08

1.8

1.7

2.40

1.36

mg/l

0.40

(40759836) Histone Ab [Presence] in Serum by Immunoblot

127

675

1.87

9.99

1.2

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

209

2.61

9.93

1.6

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

198

2.65

9.90

1.8

1.3

11.14

13.58

g/l

1.06

150

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.15

9.88

1.8

1.7

1.84

1.46

mg/l

0.14

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1846

15716

1.19

9.86

1.3

9.65

11.83

u/ml

0.77

648

6265

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2707

29936

0.87

9.82

4.1

4.3

21.38

22.13

1.67

1183

14041

(3002079) Sodium [Moles/time] in 24 hour Urine

407

2.12

9.82

1.4

1.3

159.29

176.35

mmol/24h

0.94

407

(3020876) Protein [Mass/time] in 24 hour Urine

175

1028

1.69

9.81

2.2

2.5

1.63

1.40

g/24h

0.48

106

599

(3003129) Base excess in Capillary blood by calculation

173

1014

1.69

9.78

2.5

2.0

1.10

0.40

mmol/l

1.10

153

969

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

139

767

1.80

9.71

1.3

1.2

—

(3022229) Phosphate [Moles/volume] in Urine

3.44

9.65

2.2

2.8

19.70

19.46

mmol/l

0.03

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

463

2.03

9.63

1.2

111.65

89.19

u/l

0.80

379

(3018333) Ribosomal P Ab [Presence] in Serum

119

627

1.88

9.63

1.2

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

3.57

9.58

1.3

1.2

—

32.00

titre

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

122

650

1.86

9.55

1.2

—

(3000330) Specific gravity of Urine by Test strip

605

4570

1.32

9.52

3.6

2.7

1.02

ratio

0.07

539

4050

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

116

3.16

9.47

2.3

1.7

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

125

674

1.84

9.42

1.2

1.1

—

(3049233) Organic acids panel - Urine

8.94

9.41

1.3

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

148

2.87

9.38

2.7

2.8

25.05

31.37

mg/l

0.27

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

121

648

1.85

9.33

1.2

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

127

694

1.81

9.18

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

124

673

1.83

9.17

1.2

1.1

—

(3045142) Bone marrow Pathology biopsy report

133

738

1.79

9.15

1.3

1.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.29

9.13

1.7

2.6

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

454

2.01

9.05

1.2

30.73

22.37

u/l

0.63

361

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

108

564

1.90

9.02

1.2

1.1

1.06

ratio

0.01

471

(37021550) Renin [Units/volume] in Plasma --upright

146

2.85

9.01

1.2

1.3

55.08

60.15

mu/l

0.09

111

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

184

1128

1.62

8.79

1.2

1.1

2.80

14.59

u/ml

—

(3035880) pH of Pleural fluid

413

2.04

8.74

1.3

7.40

0.09

288

(3026389) Candida sp identified in Specimen by Organism specific culture

218

1394

1.55

8.71

1.5

1.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

126

699

1.79

8.70

1.3

1.5

13.72

12.07

umol/l

1.44

115

660

(3052592) Norovirus Ag [Presence] in Stool

133

2.90

8.67

1.2

—

(40768795) Lymph node Pathology biopsy report

104

544

1.89

8.66

1.2

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

3.55

8.62

1.5

1.1

48.04

47.86

mg/l

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

292

2.24

8.61

1.6

1.4

72.49

180.18

nmol/24h

1.61

292

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

10207

103719

0.88

8.59

4.9

4.5

1.41

1.43

mmol/l

4.04

9511

97501

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

445

3271

1.36

8.47

1.6

1.5

56.77

3.77

iu/ml

0.70

575

(21494814) CD8 cells/Lymphocytes in Specimen

276

2.26

8.42

2.7

2.1

28.27

29.12

0.18

276

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

4.70

8.42

1.9

1.4

43.29

33.12

0.36

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

180

2.58

8.41

1.2

9.06

14.77

pmol/l

0.80

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.89

8.41

1.3

1.2

0.15

0.65

iu/ml

1.88

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

142

824

1.71

8.40

1.2

63.84

71.31

u/l

0.42

129

706

(3027923) C peptide [Moles/volume] in Serum or Plasma

102

537

1.88

8.34

1.6

1.33

1.24

nmol/l

0.31

411

(3020961) Endomysium IgA Ab [Titer] in Serum

676

5285

1.28

8.25

1.1

1.2

166.07

229.67

titre

0.29

195

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

562

4290

1.31

8.25

2.4

2.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

127

2.88

8.15

1.0

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

293

2.20

8.13

1.2

1.1

77.30

91.42

1.99

134

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

201

2.46

8.11

1.2

66.36

70.25

0.21

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

172

2.59

8.10

2.0

2.9

—

(3049717) Cytology report of Urine Cyto stain

444

3302

1.34

7.85

2.4

2.8

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

350

2.07

7.82

1.3

1.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.47

7.78

1.3

1.1

1.57

1.73

iu/ml

0.17

(37208534) Antinuclear antibody arbitrary concentration in serum

268

2.22

7.70

1.0

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

160

2.60

7.63

1.5

1.7

0.34

0.42

ug/l

0.74

109

(3050129) First trimester maternal screen panel - Serum or Plasma

395

5190

0.74

7.61

1.5

1.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

409

1.96

7.54

1.2

1.1

21.00

23.22

u/ml

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

122

2.84

7.53

5.8

5.7

52.40

45.96

ug/min

0.16

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

305

2.11

7.39

1.1

80.27

90.56

1.37

133

(3012920) Ethanol [Mass/volume] in Serum or Plasma

7.00

7.38

1.2

1.4

1.76

2.28

g/l

0.71

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

130

2.74

7.27

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

124

725

1.70

7.20

1.4

2.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

167

1055

1.57

7.13

2.4

1.9

27.15

26.32

mg/l

0.07

389

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

203

2.34

7.03

1.1

67.88

78.22

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

167

2.49

7.02

1.1

1.3

329.56

290.58

pmol/l

0.22

123

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

197

2.36

7.02

2.3

3.4

233.60

206.96

ug/l

0.04

197

(3012565) Volume of 24 hour Urine

413

1.92

7.02

1.8

2.2

2075.90

1999.40

0.15

373

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.30

6.93

1.0

1.2

0.53

0.79

u/ml

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

300

2.08

6.93

1.3

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

300

2.08

6.93

1.3

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

300

2.08

6.93

1.3

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

300

2.08

6.93

1.3

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

123

2.73

6.86

1.4

2.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

567

4443

1.27

6.85

1.4

1.3

230.96

231.53

miu/ml

0.01

213

2179

(3027456) Digoxin [Moles/volume] in Serum or Plasma

208

1391

1.48

6.84

3.4

3.0

0.84

0.81

nmol/l

0.52

155

1103

(3021788) Differential panel - Synovial fluid

236

1619

1.45

6.82

1.6

1.5

—

1.00

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

412

1.90

6.74

1.1

95.95

94.12

0.21

329

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

208

2.28

6.67

1.3

3.59

273.80

ug/l

1.46

114

(3033942) Copper [Moles/time] in 24 hour Urine

4.20

6.61

1.1

1.4

0.38

0.54

umol/24h

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

319

2.02

6.61

1.0

1.1

—

(3012898) Urea [Moles/volume] in Urine

2.90

6.51

1.4

1.7

149.68

170.50

mmol/l

0.41

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.66

6.49

1.9

1.6

59.85

40.43

umol/l

1.21

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.95

6.48

1.7

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

312

4139

0.74

6.47

1.5

1.08

1.21

ratio

1.97

174

2533

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

312

4139

0.74

6.47

1.5

0.92

0.95

ratio

0.61

172

2514

(3022621) pH of Urine by Test strip

953

7947

1.20

6.41

3.1

2.2

6.20

6.09

2.86

672

5159

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

118

704

1.66

6.41

2.4

1.8

2.03

1.64

u/field

0.40

397

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

10289

98972

1.12

6.40

5.2

4.5

5.99

5.85

mmol/l

14.96

9553

91710

(3035320) C reactive protein [Mass/volume] in Body fluid

124

751

1.64

6.35

3.0

2.3

33.44

28.42

mg/l

0.69

524

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

117

2.70

6.35

1.0

0.02

0.32

u/ml

0.81

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

312

4123

0.74

6.31

1.5

1.10

1.17

ratio

0.74

172

2498

(3043410) Blood group antigens tested for on Red Blood Cells

233

2.17

6.27

1.4

1.5

—

(3032641) Amino acids panel - Urine

8.03

6.26

1.2

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

215

2.21

6.20

1.8

3.5

1.79

1.94

ratio

0.33

196

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

337

4385

0.75

6.14

1.5

57.32

62.43

ug/l

1.45

280

3767

(3016330) Potassium [Moles/time] in 24 hour Urine

125

2.61

6.13

1.2

1.3

—

78.28

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

10318

104297

0.90

6.12

5.0

4.6

4.47

4.62

mmol/l

41.67

9653

98612

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.61

6.06

1.6

1.9

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

552

1.72

6.00

1.6

26.59

25.50

u/ml

0.08

115

(3003329) Lymphocytes/Leukocytes in Synovial fluid

124

764

1.61

5.96

1.6

1.5

30.73

32.14

0.16

474

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

308

4032

0.75

5.87

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

433

1.81

5.83

1.5

8.71

6.11

u/l

0.45

382

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

210

2.17

5.70

1.3

1.7

—

(3034426) Prothrombin time (PT)

297

1.97

5.65

1.3

1.2

28.80

28.54

0.13

297

(3022145) Colonoscopy Study observation

1282

11078

1.16

5.61

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

259

3452

0.74

5.60

1.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2673

24211

1.11

5.54

1.8

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

207

2.15

5.48

1.3

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

207

2.15

5.48

1.3

1.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

292

2160

1.34

5.48

1.7

1.6

12778.47

14245.43

e6/l

0.32

199

1558

(3047352) Trisomy 18 risk [Likelihood] in Fetus

255

3390

0.74

5.43

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1301

11283

1.15

5.42

2.5

2.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1113

9541

1.17

5.42

2.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

261

3448

0.74

5.34

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

314

2369

1.32

5.17

1.4

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

104

1610

0.63

5.10

2.8

2.3

13.16

13.09

0.31

104

1588

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

10458

105410

0.91

5.09

5.6

5.1

2.59

2.74

mmol/l

53.80

9758

99189

(3023383) Lactate [Moles/volume] in Pleural fluid

247

2.00

5.09

1.5

1.3

4.19

3.45

mmol/l

0.40

231

(1761482) Bacteria [#/volume] in Urine by Culture

274

2034

1.34

5.06

4.2

3.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.78

5.04

2.7

4.1

—

(40768441) Liver Pathology biopsy report

106

657

1.60

5.04

1.7

1.3

—

(3005033) Fetal Nuchal fold Thickness US

250

3288

0.75

4.98

1.5

1.24

1.26

0.35

181

2495

(3002619) Bacteria identified in Specimen by Culture

236

2.01

4.96

1.3

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

3.04

4.94

1.2

1.1

12.95

13.26

u/l

0.02

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

458

1.71

4.88

2.4

1.9

115.37

108.68

ng/l

0.18

458

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

248

1826

1.35

4.86

1.1

13.61

16.48

au/ml

0.27

517

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

290

2185

1.32

4.85

2.5

2.4

173.48

98.63

ug/min

1.64

167

1371

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.18

4.77

1.3

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

311

2372

1.30

4.77

1.9

1.7

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.60

4.68

1.3

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

495

1.66

4.64

1.1

1.3

46.00

53.64

titre

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

355

1.78

4.63

3.2

4.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

512

1.64

4.57

1.1

1.3

1068.00

518.00

titre

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1800

16114

1.12

4.57

1.9

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.61

4.52

1.4

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

115

2.41

4.49

1.1

1.6

4.23

192935.69

nmol/l

1.05

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

538

1.62

4.48

1.4

1.8

4.54

3.67

mg/l

0.79

518

(3006571) Granulocytes/Leukocytes in Synovial fluid

151

1039

1.44

4.45

1.6

1.5

61.59

55.73

1.12

100

654

(40761539) Cells [Type] in Urine sediment by Light microscopy

199

2.04

4.42

1.3

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

173

2.11

4.40

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

142

970

1.45

4.36

1.2

—

(21494434) Karyotype in Bone marrow

101

643

1.56

4.35

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1165

0.61

4.34

1.3

163.46

181.65

pmol/l

0.71

1165

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

468

1.65

4.29

2.2

1.6

1.74

3.13

u/field

0.71

334

(3033086) Enterovirus Ab [Titer] in Serum

5.43

4.23

1.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

111

727

1.51

4.21

1.2

100.85

117.56

pmol/l

2.20

111

727

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

157

2.14

4.18

2.1

2.5

6.48

8.02

mmol/l

1.27

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.55

4.18

2.6

2.7

14.31

7.23

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

110

722

1.51

4.14

1.2

1.5

—

(3050794) Legionella sp Ab [Presence] in Serum

3.00

4.13

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

459

1.64

4.09

1.9

2.0

107.62

98.25

ug/min

0.08

108

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.22

4.09

1.0

1.1

—

0.38

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

120

805

1.48

4.07

1.5

1.3

4.46

5.85

umol/l

4.16

103

717

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

293

3661

0.79

4.04

1.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3561

37266

0.92

4.02

4.8

5.2

2.70

2.85

ug/l

0.18

3142

33950

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

123

833

1.46

3.99

1.2

81.00

35.71

u/ml

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

251

1912

1.30

3.96

1.6

1.5

0.32

0.43

nmol/l

2.25

196

1523

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

215

1603

1.33

3.95

1.6

1.5

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

2.90

3.91

1.4

1.2

0.97

1.24

ml/s/173m2

0.52

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

230

1.89

3.89

1.7

2.2

204.68

108.63

ng/l

0.73

148

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10010

96826

1.08

3.85

6.7

5.6

39.35

38.55

mmol/mol

11.46

9420

91222

(3000034) Microalbumin [Mass/volume] in Urine

114

768

1.47

3.81

3.5

3.0

146.98

56.88

mg/l

0.90

566

(3004347) Hepatitis D virus Ab [Presence] in Serum

4.23

3.76

1.1

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

733

6284

1.16

3.65

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

420

1.63

3.65

1.0

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

9750

98179

0.93

3.56

4.3

3.9

1.33

1.27

mmol/l

7.23

9029

91583

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

353

2843

1.23

3.54

1.1

3.89

7.38

eliau/ml

1.12

406

(43055442) Apixaban [Mass/volume] in Serum or Plasma

2.34

3.54

1.3

1.6

95.52

110.67

ug/l

0.32

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.82

3.53

1.8

1.9

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

7.68

3.52

1.6

1.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

130

2.13

3.45

1.1

0.71

1.17

umol/24h

0.49

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

3.57

3.44

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.77

3.43

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

459

1.57

3.40

1.6

1.5

9.75

6.89

u/l

0.52

372

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

131

2.11

3.39

1.5

37.81

159.80

ng/l

1.19

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

247

1926

1.27

3.32

1.3

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

5.64

3.30

3.3

3.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

763

6615

1.15

3.29

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.88

3.24

7.4

6.2

592.27

497.68

umol/l

0.53

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.88

3.24

1.5

5.9

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

120

846

1.40

3.21

4.3

5.3

136.22

89.61

u/ml

0.28

299

(3020491) Glucose [Moles/volume] in Blood

105

724

1.44

3.18

1.8

1.7

6.85

6.47

mmol/l

0.52

525

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.26

3.16

1.9

1.4

19.00

16.04

nmol/l

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

242

2989

0.80

3.11

1.5

55.68

60.25

ug/l

1.15

242

2989

(3017704) Immunofixation for Urine

371

1.60

3.04

1.4

1.5

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

3.13

3.00

11.8

9.9

124.63

200.85

e6/l

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.13

3.00

1.0

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

103

719

1.42

2.95

1.3

2.77

4.61

u/ml

0.64

416

(3004616) Nuclear Ab [Presence] in Serum

141

1038

1.34

2.93

1.3

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

101

705

1.42

2.90

1.2

52.50

69.47

u/ml

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.32

2.89

1.1

26.92

20.54

u/l

0.59

(44786800) Granulocytes/Leukocytes in Body fluid

2.32

2.89

1.6

1.4

24.94

26.99

0.10

(3007461) Platelets [#/volume] in Blood

12190

119242

1.11

2.85

38.8

17.7

251.31

251.34

e9/l

0.01

12023

116419

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.66

2.83

1.4

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.34

2.80

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.12

2.80

1.6

1.4

471.64

609.76

nmol/l

0.41

(3008898) HLA-B27 [Presence]

441

3726

1.17

2.74

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

164

1.87

2.74

1.2

1.3

111.53

97.28

mg/l

0.04

118

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.87

2.73

1.0

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.61

2.72

1.2

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

12192

119297

1.11

2.71

38.6

17.6

90.93

90.42

25.54

12117

117909

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.51

2.71

9.3

7.4

108.13

106.14

g/l

0.15

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

12193

119309

1.11

2.71

39.7

18.0

39.65

41.67

32.99

12115

117862

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

5.93

2.67

1.0

1.1

—

(3035941) MCH [Entitic mass]

12191

119300

1.10

2.66

38.5

17.6

30.40

30.23

20.47

12116

117915

(40768443) Skin Pathology biopsy report

501

4288

1.16

2.65

1.2

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

118

2.01

2.62

1.7

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

224

1783

1.24

2.61

2.3

9.04

6.59

umol/l

0.82

169

1308

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

3.11

2.60

1.5

1.4

0.40

0.13

u/l

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

233

1.70

2.59

2.0

1.6

0.17

nmol/l

0.06

167

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

248

1.67

2.59

1.8

1.6

11.58

9.15

ug/l

1.36

248

(3026361) Erythrocytes [#/volume] in Blood

12191

119318

1.10

2.59

38.7

17.6

4.41

4.59

e12/l

240.09

11994

116122

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

622

1.42

2.58

1.3

1.1

—

(3010813) Leukocytes [#/volume] in Blood

12192

119344

1.10

2.52

38.8

17.7

7.08

6.71

e9/l

33.69

11996

116123

(3000963) Hemoglobin [Mass/volume] in Blood

12193

119359

1.10

2.51

39.1

17.8

132.91

137.87

g/l

234.63

12122

118010

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.82

2.50

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

2.24

2.43

1.3

1.4

—

291.70

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

427

1.48

2.39

1.1

218.08

198.97

iu/ml

0.13

427

(40768800) Prostate Pathology biopsy report

191

2338

0.80

2.36

1.1

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

199

2423

0.81

2.34

1.3

—

(40765096) Chromosome analysis panel by Banding

166

1.79

2.34

1.3

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

342

0.49

2.34

1.2

1.3

84.71

68.65

ug/l

0.54

342

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

202

1612

1.24

2.34

1.3

31.42

26.57

u/l

0.34

174

1384

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1065

0.71

2.33

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

430

1.47

2.32

1.1

1.3

750.00

1024.39

titre

1.02

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

505

1.43

2.28

1.1

1.2

—

(3006270) Folate [Moles/volume] in Blood

680

1.37

2.27

1.1

341.74

368.74

nmol/l

0.58

599

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

416

1.47

2.27

1.4

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

176

1.74

2.24

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.84

2.22

1.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

437

1.45

2.16

1.1

85.98

77.23

u/l

0.70

399

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

262

1.58

2.15

8.5

6.6

6.15

5.99

kpa

0.40

238

(3041918) Cholesterol [Moles/volume] in Pleural fluid

164

1.75

2.13

1.4

1.3

1.49

1.73

mmol/l

0.66

101

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

179

1.71

2.12

1.1

1.2

4.41

4.27

u/ml

0.02

145

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.47

2.12

5.7

3.6

—

(3016135) IgD [Mass/volume] in Serum

4.23

2.12

7.7

1.0

168.05

131.96

mg/l

—

(4133840) Spirometry

341

0.52

2.10

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.74

2.10

1.0

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

432

1.44

2.09

1.1

21.09

19.35

u/l

0.16

393

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.00

2.08

1.2

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

137

1064

1.27

2.05

1.4

9.45

8.05

mmol/l

2.64

131

1008

(3033099) Centromere Ab [Titer] in Serum

197

1.66

2.02

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

3.95

2.01

1.0

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

619

1.36

2.01

1.3

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

827

0.70

1.98

1.3

1.5

30.65

37.29

nmol/l

0.90

774

(3010144) Erythrocytes [#/volume] in Synovial fluid

105

792

1.31

1.97

1.4

1.3

176500.59

109203.49

e6/l

0.35

519

(44806071) Cardiolipin IgM antibody measurement

139

1.78

1.96

1.2

1.1

—

(3034891) Synovial lining cells/cells in Synovial fluid

398

1.44

1.94

1.7

1.4

5.25

3.30

0.33

(3020618) Glucose [Moles/volume] in Synovial fluid

3.29

1.93

1.0

4.74

4.58

mmol/l

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

111

1.87

1.93

1.5

1.3

203.31

375.01

u/l

0.23

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

162

1.71

1.93

1.0

1.1

0.18

4.11

u/ml

0.81

(3012494) Peanut IgE Ab [Units/volume] in Serum

407

1.43

1.92

1.1

161.29

18.57

u/ml

0.44

269

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

466

1.40

1.90

1.3

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

134

1.77

1.87

1.4

1.3

0.39

1.19

mmol/l

0.99

(3013637) Mi-2 Ab [Presence] in Serum

202

1.61

1.86

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

202

1.61

1.86

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

202

1.61

1.86

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

202

1.61

1.86

1.0

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.14

1.85

7.1

8.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1161

12317

0.92

1.83

1.7

—

7.65

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.90

1.83

4.3

2.1

0.37

0.56

u/field

0.71

(3036670) Protein [Mass/volume] in Synovial fluid

242

1.55

1.82

1.3

1.2

39.80

40.29

g/l

0.06

126

(3024263) Appearance of Synovial fluid

445

1.40

1.82

2.0

1.7

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.49

1.81

1.3

1.0

2.83

2.18

—

(4094501) Cardiovascular stress test using bicycle ergometer

228

2660

0.84

1.80

1.1

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

482

0.63

1.78

4.9

6.7

8.77

8.64

0.04

482

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.18

1.78

1.0

1.1

0.04

0.03

u/ml

0.33

(3000285) Sodium [Moles/volume] in Blood

144

1.72

1.77

1.2

136.63

139.12

mmol/l

1.01

120

(3036071) Salmonella sp Ab [Titer] in Serum

292

1.49

1.76

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

419

0.61

1.75

1.0

0.36

0.82

u/ml

1.44

414

(4034850) Laboratory test

339

2925

1.15

1.72

12.4

8.8

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.14

1.72

1.4

1.5

305.00

321.42

umol/24h

0.11

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

216

1800

1.19

1.71

1.3

—

(3002256) Pathology report gross observation

1408

13062

1.07

1.70

1.3

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

3.80

1.69

1.0

1.20

1.38

u/field

—

(3036048) Francisella tularensis Ab [Titer] in Serum

162

1.65

1.67

1.1

1.2

—

520.00

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

147

1.68

1.66

5.0

8.9

63.12

72.53

0.77

117

(3016750) Collection duration of Urine

530

1.34

1.65

2.6

2.2

506.52

496.10

min

0.38

415

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.12

1.64

7.0

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

482

0.65

1.62

2.4

3.4

36.53

45.38

1.46

482

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.77

1.62

1.9

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

282

3203

0.87

1.62

1.6

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

307

1.45

1.60

1.5

1.7

37.96

40.84

g/l

2.01

307

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.00

1.59

2.0

2.5

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

105

1.79

1.56

1.0

1.1

435.29

304.16

u/ml

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

326

1.43

1.54

1.7

2.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

154

0.45

1.54

1.0

1.1

1.10

1.19

mom

—

154

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

166

1.61

1.54

1.0

1.1

0.08

0.47

u/ml

1.16

(1617658) Protocol used for examination of sentinel lymph nodes

521

0.68

1.52

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

238

1.49

1.51

8.8

6.6

5.64

5.33

kpa

0.34

238

(3045683) HLA typing for celiac disease panel - Blood or Tissue

660

1.29

1.50

1.0

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

183

1.57

1.49

1.1

1.2

8.82

7.28

u/ml

0.11

148

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

173

1436

1.19

1.48

1.1

2.24

2.90

0.41

270

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.40

1.46

1.2

1.3

—

(3025130) Human papilloma virus identified in Specimen

186

1556

1.18

1.46

1.8

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

232

1.49

1.46

1.3

51.58

55.83

0.25

197

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

9683

94474

1.04

1.45

33.7

14.6

333.70

333.58

g/l

0.59

9632

93852

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

154

1.60

1.43

1.0

1.1

0.37

0.38

u/ml

0.01

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

116

1.70

1.42

2.0

2.1

2.98

5.71

nmol/l

0.65

110

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

109

1.72

1.40

1.3

1.4

5.31

11.20

1.42

(3004775) Volume in Urine collected for unspecified duration

728

1.26

1.40

2.5

2.3

723.72

639.57

1.20

516

(3019174) dRVVT (LA screen)

1.89

1.38

1.1

1.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.58

1.34

1.2

1.3

—

(40762887) Creatinine [Moles/volume] in Blood

2.05

1.34

1.5

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

205

1745

1.16

1.33

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

205

1.49

1.32

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

205

1.49

1.32

1.3

1.1

—

(3047189) Immunofixation for 24 hour Urine

337

1.38

1.32

1.3

1.9

—

(1002224) Polysomnography panel

517

5582

0.91

1.30

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.89

1.28

1.0

1.2

1.85

1.86

umol/24h

0.01

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

1.94

1.28

2.4

2.5

58.40

56.93

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

179

1515

1.17

1.26

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.71

1.25

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.91

1.23

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

1.76

1.22

1.0

1.15

0.22

u/ml

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

439

3947

1.10

1.21

3.1

3.0

107.88

53.52

u/ml

0.37

426

3816

(3041806) Other cells [#/volume] in Blood by Manual count

788

0.78

1.21

1.6

1.4

0.53

0.52

e9/l

0.21

788

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

142

1186

1.18

1.19

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

132

1541

0.84

1.16

1.3

1.4

7.32

7.03

mmol/l

0.46

123

1366

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

363

1.33

1.15

1.3

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

205

1.45

1.13

1.3

1.1

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

182

1.47

1.09

1.0

3.35

3.54

kpa

0.32

154

(40768793) Breast Pathology biopsy report

163

1856

0.87

1.07

1.4

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

119

1.58

1.06

1.2

1.1

—

(4212803) Bone marrow aspirate examination

1.80

1.05

1.1

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

2.10

1.04

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

387

4174

0.91

1.02

1.7

1.6

4.29

4.07

mg/l

0.17

313

2901

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.24

1.01

1.0

—

(4281824) Cell count and differential, peritoneal fluid

102

842

1.20

1.01

1.2

—

(3006598) pH of Arterial cord blood

187

1.43

0.97

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

187

1.43

0.97

1.0

7.17

7.27

kpa

0.09

161

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.69

0.95

1.1

1.2

—

(44813793) Dust mix specific IgE antibody measurement

804

1.19

0.94

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

216

2385

0.89

0.92

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

216

2384

0.89

0.91

1.2

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

503

0.76

0.91

2.0

2.2

2.77

3.05

ug/l

0.10

469

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1251

11826

1.05

0.89

2.4

2.2

12.66

13.35

nmol/l

2.06

1091

10883

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.93

0.89

2.0

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

225

1.36

0.88

1.2

1.1

20.20

20.13

mmol/l

0.04

206

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

531

1.23

0.88

7.7

6.8

4053.44

6869.21

u/ml

0.17

104

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

1.65

0.87

1.0

5.17

0.34

u/ml

0.50

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

226

1.36

0.86

1.3

31.71

41.97

0.87

149

(3001729) Color of Synovial fluid

1.70

0.82

1.5

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.57

0.80

1.0

171.64

164.15

g/l

0.86

(3005011) Chlamydia sp Ab [Titer] in Serum

145

1.43

0.80

1.2

1.5

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

535

0.79

1.2

8.44

9.34

mm/h

0.33

535

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

129

1.45

0.79

1.1

1.0

—

(3025577) Chromium [Mass/volume] in Blood

491

0.78

2.0

2.2

1.70

2.26

ug/l

1.11

403

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.80

0.78

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

160

0.62

0.76

1.1

10.89

6.59

u/ml

—

160

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.15

0.75

1.0

1.4

—

(40763590) HLA-DQ beta [Type]

2.15

0.75

1.0

—

(3013862) HLA-DP [Type]

2.15

0.75

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

284

1.29

0.75

1.4

1.2

—

(40760409) HLA-A [Type] by High resolution

2.06

0.74

1.0

—

(40760410) HLA-B [Type] by High resolution

2.06

0.74

1.0

—

(46236302) HLA-C [Type] by High resolution typing

2.06

0.74

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

1.58

0.71

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

227

1.31

0.69

1.1

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

150

1.38

0.69

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

101

1.47

0.66

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.57

0.65

1.0

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

309

1.25

0.64

2.0

1.7

153.20

118.49

au/ml

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.47

0.63

1.4

1.2

—

364.04

—

(3007700) Barley IgE Ab [Units/volume] in Serum

1.59

0.62

1.1

1.0

0.27

0.91

u/ml

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

175

1900

0.91

0.62

1.1

0.95

0.49

u/ml

0.45

619

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

329

1.23

0.61

1.1

1.3

2.58

12.37

u/ml

1.87

229

(3025018) Bordetella pertussis Ab [Titer] in Serum

785

1.15

0.61

1.1

1.2

—

(4211845) Urine protein measurement

483

1.19

0.61

2.8

—

(3044316) Mercury [Moles/volume] in Urine

0.00

0.60

0.0

2.1

—

7.58

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

6.47

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1519

15439

0.97

0.59

1.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

469

4890

0.95

0.58

2.0

1.8

44.23

40.47

nmol/l

1.72

460

4793

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.58

0.0

1.2

—

0.40

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

130

1.37

0.57

1.1

1.2

1.17

0.91

u/ml

0.10

130

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.48

0.56

1.0

1.1

88.00

101.20

titre

0.21

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

610

1.15

0.53

1.8

2.0

2.03

3.22

u/ml

0.67

202

(3014891) Appearance of Pleural fluid

1.43

0.52

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

194

1.27

0.51

1.4

1.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

116

1.36

0.51

1.1

24.16

12.15

u/ml

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

411

1.18

0.50

2.4

2.2

7.95

9.71

mg/l

1.42

351

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

331

0.81

0.49

1.1

36.71

60.70

u/ml

1.98

326

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

332

3093

1.06

0.49

1.2

1.1

2.89

2.50

u/ml

0.21

199

1725

(3006462) Nitrate [Presence] in Urine

440

1.17

0.48

2.8

2.9

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

331

1.19

0.48

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

127

1.32

0.46

1.3

49.17

44.23

mg/l

0.13

107

(3015076) Soybean IgE Ab [Units/volume] in Serum

792

0.88

0.45

1.1

1.37

0.88

u/ml

0.40

254

(44806420) Estimation of glomerular filtration rate

100

1093

0.90

0.45

2.2

2.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

566

1.13

0.43

1.4

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.41

0.43

1.5

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.39

0.41

1.1

—

(3034092) Cytoplasmic Ig cells/cells in Blood

148

0.73

0.41

10.3

5.5

0.28

0.20

0.54

148

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

145

1547

0.92

0.41

1.1

2.47

4.07

eliau/ml

1.66

762

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

338

1.17

0.40

2.0

1.9

—

(3009677) Dengue virus Ab [Presence] in Serum

1.45

0.40

1.0

1.1

—

(3013762) Body weight Measured

1.45

0.40

1.4

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

122

1.30

0.39

1.0

1.24

1.19

u/ml

—

(4146454) Self-monitoring of blood glucose

111

1005

1.09

0.38

3.2

2.7

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.41

0.35

1.7

2.2

0.67

0.70

ug/l

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.41

0.35

1.0

1.1

0.08

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.35

0.34

1.0

1.2

191.33

361.65

nmol/l

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

834

1.09

0.33

1.1

18.48

7.08

iu/ml

1.50

223

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

461

0.88

0.33

1.0

12.07

12.85

u/ml

0.08

305

(3014133) Dog dander IgE Ab [Units/volume] in Serum

219

2280

0.95

0.33

1.1

5.51

4.59

u/ml

0.28

124

1245

(4038314) Semen analysis, post vasectomy

142

0.76

0.33

1.2

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

173

1.20

0.29

8.5

6.4

9.96

10.85

0.67

173

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

161

0.80

0.29

1.1

1.9

2.33

2.40

ug/l

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.27

0.27

1.1

—

(40758292) HTLV I+II Ab panel - Serum

193

1.18

0.27

1.3

—

(3001556) Androgen free Index in Serum or Plasma

139

1.21

0.26

1.4

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

207

2136

0.96

0.25

1.1

7.18

6.29

u/ml

0.14

112

1045

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

200

2063

0.96

0.24

1.3

3.28

3.86

ug/l

1.28

183

1925

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.27

0.22

1.8

4.1

—

(40762814) Titanium [Mass/volume] in Blood

123

0.80

0.22

2.5

2.6

7.54

3.30

ug/l

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

225

2139

1.04

0.21

3.7

2.9

27.89

28.03

mg/l

0.02

147

1467

(40760512) CD34 cells/cells in Bone marrow

0.00

0.21

0.0

1.1

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

53.45

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

106

1.21

0.21

2.1

1.5

—

(3012138) Guinea pig epithelium IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.93

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.20

0.0

1.3

—

(3010937) Rubella virus Ab [Presence] in Serum

1.25

0.20

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

706

1.06

0.18

2.3

2.0

46.02

1047.34

pmol/l

0.71

112

(3051101) Glucose [Moles/volume] in Cord blood

162

0.85

0.18

4.5

6.3

8.62

8.13

mmol/l

0.24

162

(3022670) pH of Venous cord blood

1.15

0.17

1.0

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.13

0.17

1.3

1.2

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

146

1.15

0.17

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1193

11642

1.01

0.16

4.7

4.6

32.46

32.11

0.48

881

7887

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

827

1.05

0.15

1.0

1.1

15.72

17.83

u/ml

0.26

354

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

337

1.08

0.15

1.3

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

369

3567

1.02

0.15

2.0

1.8

194.69

205.61

pmol/l

0.99

351

3407

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

322

3110

1.02

0.14

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4414

43392

1.01

0.13

2.0

1.8

1.43

1.35

mmol/l

3.35

3753

37108

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

514

1.06

0.12

7.4

7.6

30.95

85.16

ug/l

0.51

350

(3020874) Milk IgE Ab [Units/volume] in Serum

905

0.96

0.12

1.2

6.36

3.46

u/ml

0.22

350

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

135

0.88

0.11

1.2

1.3

5.69

5.81

mmol/l

0.13

135

(3008401) Mugwort IgE Ab [Units/volume] in Serum

273

2642

1.02

0.11

1.1

1.11

1.25

u/ml

0.18

143

1317

(3003888) Timothy IgE Ab [Units/volume] in Serum

283

2748

1.02

0.09

1.1

6.41

6.84

u/ml

0.16

163

1624

(3010726) Horse dander IgE Ab [Units/volume] in Serum

263

2642

0.98

0.09

1.1

2.55

2.57

u/ml

0.01

151

1450

(3020650) Glucose [Presence] in Urine

386

0.95

0.09

1.5

0.08

0.03

estimate

0.24

386

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

436

0.95

0.09

1.0

1.1

22.80

10.29

u/ml

—

(3022475) Manganese [Moles/volume] in Blood

1.12

0.09

1.2

1.5

0.19

0.15

umol/l

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.82

0.08

1.0

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

515

0.96

0.08

2.0

195.60

196.95

u/l

0.04

509

(3032868) Hemoglobin electrophoresis panel in Blood

131

0.90

0.07

1.6

1.5

—

(4015189) Microbial culture of sputum

191

0.93

0.06

1.4

2.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

867

0.98

0.05

1.3

1.1

9.29

6.84

u/ml

0.11

276

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

110

1.08

0.03

4.7

3.4

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

512

1.02

0.03

3.2

4.3

8.52

9.01

mg/l

0.25

414

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

126

0.94

0.02

1.2

1.0

0.42

0.79

u/ml

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

126

0.94

0.02

1.3

2.9

—

(40765089) Chromosome analysis panel - Blood by G-banded

621

0.99

0.01

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

412

0.98

0.01

2.7

3.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

174

0.96

0.01

1.5

1.2

7.18

7.54

mmol/l

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

135

1.02

0.00

1.3

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

454

1.00

0.00

2.5

3.2

88.25

121.13

au/ml

0.39

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

268

0.99

0.00

1.0

1.1

19.71

32.76

iu/ml

1.30

268

(3009871) Measles virus Ab [Titer] in Serum

384

1.00

0.00

1.9

1.6

4706.67

3070.77

titre

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

204

1.02

0.00

1.4

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.92

-0.00

1.1

1.3

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

-0.00

0.0

1.3

—

8.19

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.1

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.91

-0.00

1.0

1.8

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.9

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.88

-0.00

5.3

7.0

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_CONVU_NOT_ELSEW_CLASSIFIED – Convulsions, not elsewhere classified

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Convulsions, not elsewhere classified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Convulsions, not elsewhere classified (R18_CONVU_NOT_ELSEW_CLASSIFIED)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints